Previous Article | Next Article ![]()
Microbiology and Molecular Biology Reviews, June 2001, p. 261-287, Vol. 65, No. 2
Centro de Biología Molecular "Severo Ochoa"
(CSIC-UAM), Universidad Autónoma, Canto Blanco, 28049 Madrid,
Spain
1092-2172/01/$04.00+0 DOI: 10.1128/MMBR.65.2.261-287.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
29 Family of Phages
SUMMARY
INTRODUCTION
GENERAL FEATURES OF PHAGES
29, B103, AND GA-1
SEQUENCE ANALYSIS OF THE GA-1 GENOME
GENETIC AND TRANSCRIPTIONAL ORGANIZATION
TRANSCRIPTIONAL REGULATION
Early Promoters A2b and A2c and Late Promoter A3:
Transcriptional Regulation by Proteins p4 and p6
Early Promoter C2: Transcriptional Regulation by Protein
p6
Early Promoters C1, C1a, and C1b Present in
29,
B103, and GA-1, Respectively
Promoter A1, Driving Synthesis of the pRNA
Other Promoters in the
29 Genome
Other Promoters in the GA-1 Genome
TRANSCRIPTIONAL TERMINATION
PROTEIN-PRIMED MECHANISM OF DNA REPLICATION
INITIATION OF DNA REPLICATION
DNA Polymerase-TP Heterodimer Formation
Sliding-Back Mechanism
Transition from Protein-Primed to DNA-Primed
Replication
THE FOUR MAIN PROTEINS REQUIRED FOR IN VITRO DNA
REPLICATION
DNA Polymerase
C-terminal domain of
29 DNA polymerase.
N-terminal domain of
29 DNA polymerase.
(i)
Proofreading.
(ii) Strand displacement.
Coordination between synthesis and degradation.
Terminal Protein p3
DBP Protein p6
SSB Protein p5
OTHER GENES AND OPEN READING FRAMES DOWNSTREAM OF GENE 2 IN
29 AND B103
Gene 1 of
29
GA-1 OPERONS CONTAINING OPEN READING FRAMES M-O AND P-T
EARLY OPERON LOCATED AT THE RIGHT SIDE OF THE PHAGE
GENOMES
Gene 17
Gene 16.7
LATE OPERON
Gene 8.5, Encoding the Head Fiber Protein
Structural Phage Proteins and
29 Phage Morphogenesis
Prohead formation.
DNA translocating/packaging machine.
(i) Connector.
(ii) pRNA ring.
(iii) ATPase protein p16.
Putative mechanism of
29 DNA packaging.
Phage maturation.
Lysis cassette.
(i) Holin-encoding genes of
29, B103, and GA-1.
(ii) Peptidoglycan hydrolase-encoding genes of
29, B103,
and GA-1.
CONCLUSIONS AND FUTURE PERSPECTIVES
ACKNOWLEDGMENTS
REFERENCES
SUMMARY
|
|
|---|
Continuous research spanning more than three decades has made the Bacillus bacteriophage
29 a paradigm for several molecular mechanisms of general biological processes, such as DNA replication, regulation of transcription, phage morphogenesis, and phage DNA packaging. The genome of bacteriophage
29 consists of a linear double-stranded DNA (dsDNA), which has a terminal protein (TP) covalently linked to its 5' ends. Initiation of DNA replication, carried out by a protein-primed mechanism, has been studied in detail and is considered to be a model system for the protein-primed DNA replication that is also used by most other linear genomes with a TP linked to their DNA ends, such as other phages, linear plasmids, and adenoviruses. In addition to a continuing progress in unraveling the initiation of DNA replication mechanism and the role of various proteins involved in this process, major advances have been made during the last few years, especially in our understanding of transcription regulation, the head-tail connector protein, and DNA packaging. Recent progress in all these topics is reviewed. In addition to
29, the genomes of several other Bacillus phages consist of a linear dsDNA with a TP molecule attached to their 5' ends. These
29-like phages can be divided into three groups. The first group includes, in addition to
29, phages PZA,
15, and BS32. The second group comprises B103, Nf, and M2Y, and the third group contains GA-1 as its sole member. Whereas the DNA sequences of the complete genomes of
29 (group I) and B103 (group II) are known, only parts of the genome of GA-1 (group III) were sequenced. We have determined the complete DNA sequence of the GA-1 genome, which allowed analysis of differences and homologies between the three groups of
29-like phages, which is included in this review.
INTRODUCTION
|
|
|---|
The genus Bacillus incorporates many species of gram-positive, aerobic, endospore-forming bacteria that normally inhabit the soil or decaying plant material. In these habitats, a large variety of phages have been isolated that infect bacilli. All of these phages isolated so far have some common features. First, they all contain double-stranded DNA (dsDNA), and second, the virions have prolate icosohedral heads and are tailed. Modern phage taxonomy is based on properties of the virion and its nucleic acid (see references 74 and 131). The order of tailed phages, named Caudovirales, are classified into three families: Myoviridae (phages with contractile tails), Podoviridae (phages with short tails), and Siphoviridae (phages with long noncontractile tails). For a general review on tailed bacteriophages, see reference 4. In addition to taxonomy based on properties of the virion and its nucleic acid, phages can be divided into three groups based on their infection cycle. The first group contains lytic phages that complete their life cycle within a well-defined period after infection and are unable to lysogenize their host. The second group is formed by the so-called pseudo-temperate phages. These are virulent phages with an extended and irregular latent period. Although this stage mimics lysogeny, it does not involve a stable prophage. The third group contains the temperate phages. The genomes of these phages are able to integrate into the host genome and can be maintained in this lysogenic stage for many generations. Generally, during this stage, the cells are immune to infection with the same phage.
This review specifically focuses on the
29-like genus of phages,
which includes, in addition to
29, phages PZA,
15, BS32, B103,
M2Y (M2), Nf, and GA-1. They are all lytic phages that belong to the
Podoviridae family. Most of these phages infect
Bacillus subtilis, but often they also infect other related
species such as Bacillus pumilus, Bacillus
amyloliquefaciens, and Bacillus licheniformis. Phages
of this genus have been subclassified into three groups based on
serological properties, DNA physical maps, peptide maps and partial or
complete DNA sequences (164, 220, 222). The first group
includes phages
29, PZA,
15, and BS32; the second group includes
B103, Nf, and M2Y; and the third group contains GA-1. Interestingly,
the classification of these phages coincides with their geographical
distribution. Thus, the phages belonging to group I were isolated in
the United States (169), those belonging to group II were
isolated in Japan (91, 113, 191), and GA-1 (group III) was
isolated in Europe (39).
The genomes of the
29-like phages consist of a linear dsDNA molecule
of about 20 kb that has a phage-encoded protein, named terminal protein
(TP), covalently attached at each 5' DNA end. The DNA sequences of the
complete genomes of
29 and PZA (83, 84, 161, 216, 221,
224) belonging to group I and that of B103 (163)
belonging to group II have been determined. However, only parts of the
GA-1 sequence, belonging to group III, have been determined so far
(78, 86, 111, 114, 222). To gain a comprehensive
understanding of the relatedness of the three groups of phages, we have
determined the complete DNA sequence of GA-1. The genomes of
29 and
B103 are 19,285 and 18,630 kb, respectively (163, 216).
However, the GA-1 genome was reported to be approximately 21.5 kb
(220, 223). Thus, an additional incentive to determine the
complete DNA sequence of GA-1 was to gain insight into possible
additional coding sequences present on the GA-1 genome.
Phage
29 has been subject to extensive studies, and the results have
led to the understanding of several molecular mechanisms of general
biological processes, such as DNA replication, regulation of
transcription, phage morphogenesis, and phage DNA packaging. These
various topics will be discussed in this review, and attention is
focused specifically on progress made during the last few years. In
general, the views presented are based on results obtained with
29,
since most studies concerned analysis of this phage. In addition, an
integrated overview of homologies and differences between the three
groups of the
29 genus based on the complete DNA sequences of
29
(group I), B103 (group II), and GA-1 (group III) is presented.
GENERAL FEATURES OF PHAGES
29, B103, AND GA-1
|
|
|---|
The
29-like phages are the smallest Bacillus phages
isolated so far and are among the smallest known phages containing
dsDNA. The sizes of the phage particle of each of the three groups of
29-like phages are shown in Table 1.
Phage
29 was first isolated by Reilly (169) from garden
soil. Phage B103 was first isolated from a nonspecified lysed
Bacillus culture (91), and phage GA-1 was first
isolated by Bradley (39) from rotting lawn mowings. Electron microscopy analysis showed that the phage particles of
29, B103, and GA-1 have a sixfold radial symmetry and a short noncontractile tail tube. A schematic representation of a
29 phage
particle in which each protein is indicated is shown in Fig.
1. Analysis of the host range showed that
29 was able to infect B. subtilis strains 168, 110NA, and Marburg, B. amyloliquefaciens H, and several
strains of B. licheniformis and B. pumilus
(reviewed in reference 177). The host range of B103 has
not been studied, but it is known to infect B. subtilis 9/3
(163). Finally, GA-1 was shown to infect lytically
Bacillus species strain G1R (39). Arwert and
Venema (10) showed that GA-1 is unable to infect the
standard B. subtilis strain 168. Although sequence analysis of G1R 16S rRNA showed that Bacillus strain G1R is most
closely related to B. pumilus, GA-1 is unable to infect
B. pumilus strains BP1 or B205-L (J. A. Horcajadas,
unpublished results). Therefore, the species identification of
Bacillus strain G1R, the specific host of GA-1, remains
unclear.
|
|
SEQUENCE ANALYSIS OF THE GA-1 GENOME
|
|
|---|
The DNA sequence of the complete genomes of
29 (group I)
(83, 84, 216, 221, 224) and B103 (group II),
(163) are known, and they consist of 19,285 and 18,630 bp,
respectively. However, only noncontinuous parts of the GA-1 genome have
been sequenced before. These include (i) the left (168 bp; GenBank
accession number M19512) and right (168 bp; M19519) terminal nucleotide sequences (222); (ii) the central region containing the
early promoters A2b and A2c and the late promoter A3 (354 bp; AJ133524) (111); (iii) gene 6 encoding the dsDNA binding protein
(DBP) p6 (342 bp; AF148209) (78); (iv) gene 5 encoding the
single-stranded DNA (ssDNA) binding protein (SSB) p5 (513 bp; AJ244026)
(86); (v) gene 4 encoding the transcriptional regulatory
protein p4G (405 bp; AJ133525) (111); (vi) the
region spanning genes 3 and 2 encoding the TP (p3) and DNA
polymerase (p2), respectively (2,668 bp; X96987)
(114); and (vii) a region downstream of gene 2 (549 bp; AJ294726) (A. Bravo and M. Salas, unpublished data). Genes 6 through 2 lie in the same order as the corresponding genes of phages
29 and B103. Where possible, the individual sequences were
integrated in larger contigs and gaps were filled using primers based
on the published sequences and purified GA-1 as template DNA. Next, the
remaining part (~17 kbp) of the GA-1 genome sequence was determined
of both strands by a primer-walking strategy using purified phage GA-1
DNA as template.
The genome of GA-1 was shown to have a total size of 21,129 bp. The
complete nucleotide sequence has been deposited in the EMBL/GenBank/DDBJ nucleotide sequence database and was assigned accession number X96987. Whereas the G+C content of GA-1 is 34.7%,
those of
29 and B103 are 40.0 and 37.7%, respectively. Next,
computer-assisted and manual analysis of the DNA sequence were used to
identify open reading frames (ORFs), direct and inverted repeats, and
putative promoters, ribosomal binding sites, and Rho-independent
transcriptional terminators. The deduced amino acid sequences of the
various ORFs were compared with protein sequences present in the
29
and B103 genomes as well as with those present in available databases.
In cases where the deduced amino acid sequences of the identified ORFs
or genes showed significant homology to those of the
29 and B103
genes, they were given numbers according to the nomenclature used for
these phages. The remaining ORFs were identified with letters. The data
obtained were used to construct a putative genetic and transcriptional
map of GA-1, which is shown, together with those of
29 and B103, in
Fig. 2. This figure shows that genes 2 to
6, 7 to 16 (with the exception of gene 8.5, which is lacking in GA-1),
and 17 and 16.7 are conserved in all three genomes. Characteristics of
the proteins synthesized by these GA-1 genes and their levels of
similarity to corresponding proteins of
29 and B103 are given in
Table 2, which shows that for all the
homologous genes shared by
29, B103, and GA-1, those of GA-1 are
less conserved than those of
29 and B103. This confirms that within
the family of
29-related phages, GA-1 is the most distantly related
one, as suggested previously (164, 220, 222). Features of
the putative proteins synthesized by the GA-1 ORFs are given in Table
3.
|
|
|
GENETIC AND TRANSCRIPTIONAL ORGANIZATION
|
|
|---|
Generally, genes with related functions are clustered in phage
genomes (4), and Fig. 2 shows that
29, B103, and GA-1
are no exception to this rule. In addition, Fig. 2 shows that in most aspects, the genomes of
29, B103, and GA-1 are similarly organized. In all three genomes the genes and ORFs are organized in
operons. Depending on the time when they are first expressed
during the infection cycle, these can be divided into early and late
operons. In all three genomes the early-expressed
operons are transcribed leftward and the single late-expressed
operon is transcribed rightward. The genes present in the late
operon (genes 7 through 16), which is located in the central
part of the genome, encode phage structural proteins, proteins involved
in phage morphogenesis, and proteins required for lysis of the host.
All three genomes contain an early-expressed operon that is
divergently transcribed with respect to the late operon (Fig.
2). Genes 6, 5, 3, and 2 of this operon encode the four main
proteins required for phage DNA replication. The operon also
contains gene 4, which encodes the transcriptional regulator protein.
In addition to its role in phage DNA replication, protein p6 also has a
role in transcriptional regulation (14, 69, 219). Note
that this operon of GA-1 is smaller than the corresponding ones
of
29 and B103. Another early-expressed operon is located at
the right side of the phage genomes. However, as described in more
detail later, only two genes of this operon, 17 and 16.7, are
conserved in all three phage genomes. Finally, another feature shared
by all three phages is the presence of a region located in the left
part of the genome that encodes an RNA (pRNA) which is required for
packaging of phage DNA.
The genome of GA-1 is about 1.8 and 2.5 kb larger than those of
29
and B103, respectively. Although the structural organization of GA-1
genome is similar to that of
29 and B103, it contains additional sequences, located at both genome ends, that may
encode several proteins, counterparts of which are not present in the genomes of
29 and B103 (see Fig. 2).
TRANSCRIPTIONAL REGULATION
|
|
|---|
The (putative) promoters and transcriptional start sites, for
these cases already determined, are listed in Table
4. When appropriate, the nomenclature of
the GA-1 promoters was adapted to that of
29 and B103. Expression of
most
29 and GA-1 promoters has been studied. As indicated in Table
4, most of the promoters contain the sequence TG positioned 1 bp
upstream of the
10 sequence. This additional sequence is
characteristic of the so-called
10 extended promoters first described
for Escherichia coli promoters (123, 165). At
least in E. coli, the extension of the
10 region is able
to compensate for the absence of a good
35 box, helping the sigma 70 RNA polymerase to recognize and bind such promoters (123, 128,
165). The additional TG sequence is also frequently found in
A-dependent B. subtilis promoters (106,
152). Possible involvement of the TG motif in promoter strength
has been recently studied for the
29 promoters A1, A2c, and A3
(46). In all three promoters, mutation of the TG motif
impaired the binding of the
A-RNA polymerase to the
promoter. These and additional results support the view that the TG
motif provides contact sites for B. subtilis
A RNA polymerase that are important for a specific role
in the first steps of transcription (46).
|
The B. subtilis
-amylase promoters amyP and
amyP2 contain the TGTG sequence located 1 bp upstream of its
10 region, called the
16 region. Mutation analysis of the
16
region of these promoters showed that it significantly affected the in
vitro promoter strength (217). In addition, a large
portion of known gram-positive bacterial promoters contain the
16
TRTG motif (in which R is a purine), suggesting that not only the
10
extended TG motif but also the
16 region is important for promoter
strength (217). The
16 region is present in the
following phage promoters: A1 and A2b of
29, A1 of B103, and A1c, A3
and C2 of GA-1 (Table 4). Possible involvement of the
16 region in
the activity of these phage promoters has not been studied yet.
Early Promoters A2b and A2c and Late Promoter A3: Transcriptional Regulation by Proteins p4 and p6
As described above, the structural organization of the centrally
located late operon and the divergently oriented early
operon is conserved in the genomes of
29, B103, and GA-1. In
all three phage genomes the promoters that drive the expression of
these early and late genes are localized in a short intergenic region between these two operons. The transcriptional regulation of
these promoters has been studied extensively for
29 (for reviews,
see references 171 and 182). Two strong promoters named
A2c and A2b drive the expression of the early operon of
29
containing genes 6 to 1. The late
29 operon is transcribed
from a single promoter named A3 (16, 136, 137, 149, 197).
The transition from early to late
29 transcription is controlled by
29 protein p4, the product of the early gene 4. Protein p4, which is
a dimer in solution, binds to its cognate DNA binding sites as a
tetramer (142), contacting only one side of the DNA helix
(172). The intergenic region comprising promoters A2c,
A2b, and A3 contains two p4 binding sites. The center of one of these
is located at position
82 relative to the transcription start site of
the late promoter A3 (15). Whereas this promoter contains
a good consensus sequence at the
10 region for the vegetative
B. subtilis
A RNA polymerase, it lacks a
typical
35 box (Table 4). Therefore, the RNA polymerase alone does
not bind efficiently to the A3 promoter, which explains why the
downstream operon is not expressed during early infection
times. Activation of the A3 promoter requires binding of protein p4 to
the p4 binding site upstream of the A3 promoter. The main role of
protein p4 is to stabilize the binding of RNA polymerase to the A3
promoter as a closed complex, and the protein has little effect on the
rest of the steps of the initiation process (157).
The
29 promoters A2c and A2b drive the expression of the early
operon containing genes 6 to 1. Of these, promoter A2b is the
one located closest to the oppositely oriented late promoter A3;
promoter A2c is located proximal to gene 6. Both early promoters are
repressed by protein p4. The p4 binding site that is located upstream
of the late A3 promoter and is required for activation of this
promoter, as described above, partially overlaps the early A2b
promoter. Binding of protein p4 to this site occupies the
35 region
of the A2b promoter, preventing the expression of this promoter. Thus,
protein p4 activation of the late promoter A3 is accompanied by an
efficient repression of the A2b promoter (172). Expression
of the other early promoter, A2c, is also repressed by protein p4, but
this occurs through a totally different mechanism. In addition to the
p4 binding site upstream of the late promoter A3, another p4 binding
site is located upstream of promoter A2c (centered at position
72
relative to the transcription start site of A2c). Protein p4 binding to
this site is stabilized in the presence of RNA polymerase, indicating
that the proteins bind cooperatively to the DNA. In this situation, the
RNA polymerase can generate abortive initiation transcripts but is
unable to escape from the A2c promoter (150). Thus,
repression of the A2c promoter occurs by overstabilization of the RNA
polymerase to this promoter (148). Interestingly, both
repression at the A2c promoter and activation of the A3 promoter
involve interaction between a region of protein p4 containing
Arg120 and the C-terminal domain of the RNA polymerase
subunit (140-143, 150, 151, 171).
Recently it was demonstrated that expression of the
29 A2c, A2b, and
A3 promoters is regulated by the viral protein p6 in addition to
protein p4 (69). Protein p6 is an abundantly
early-expressed dsDNA binding protein that was shown previously to play
an important role in initiation of phage DNA replication (see below).
Elías-Arnanz and Salas (69) showed that protein p6
promotes p4-mediated repression of the A2b promoter and activation of
the A3 promoter by enhancing binding of p4 to its recognition site at
promoter A3. In addition, protein p4 promotes p6-mediated repression of
the A2c promoter by favoring the formation of a stable p6-nucleoprotein
complex that interferes with RNA polymerase binding to promoter A2c.
Although transcriptional regulation of the equivalent promoters of B103
has not been studied, conservation of the main characteristics of this
region regarding the A3 and A2b promoters suggests that transcription
of these promoters may be regulated in a similar way to those of
29.
Results that at least partially support this assumption may come from
the analysis of the corresponding region of phage Nf (147,
158), which belongs to the same group of phages as B103. First,
it was shown that activation of the late A3 promoter of Nf requires the
Nf-encoded protein gpF (homologue of the
29 protein p4);
(147). Second, Nuez and Salas (158) showed
that activation of the Nf A3 promoter is responsive to the
29
protein p4 in a similar way to that observed for the
29 A3 promoter.
A first in vivo and in vitro analysis of the transcriptional regulation
of the equivalent promoters of GA-1 has been reported recently
(111). The in vivo activity of the GA-1 A2b and A2c promoters was shown to diminish 10 min after infection, whereas at this
time the expression of the late A3 promoter increased significantly.
The GA-1-encoded protein p4 (named p4G, 53% similar to
29 p4) was purified and used to study its involvement in regulation of these promoters in vitro. As in
29, a p4G binding
site is located upstream of the late A3 promoter that overlaps with the early A2b promoter. As in
29, binding of p4G to this
site prevented the binding of RNA polymerase to the GA-1 early A2b
promoter. Surprisingly, however, binding of p4G to this
site had no effect on the in vitro expression of the late A3 promoter
of GA-1. Both in the absence and in the presence of p4G,
promoter A3 was expressed efficiently in vitro. Thus, in contrast to
the situation in
29, p4G is not required in vitro to
activate the expression of the GA-1 A3 promoter. Moreover, in contrast
to the
29 protein p4, the GA-1 protein p4G was shown not
to interact with the RNA polymerase
subunit (111).
Although the A3 promoter of GA-1 was active in the absence of
p4G in in vitro assays, it was not active at early
infection times in vivo. In addition, in vivo activation of the A3
promoter was completely blocked when protein synthesis was prevented
just before infection. Together, these results suggested that the A3
promoter may be repressed in vivo by a host-encoded protein and that
protein p4G may function as an antirepressor, permitting A3
expression at late infection times. Finally, it is intriguing that the
GA-1 A3 promoter, which, like the A3 promoters of
29 and B103, lacks
a good
35 box, is expressed efficiently in vitro. Studies are under
way to unravel the mechanisms that underlie the observed differences in
regulation of the
29 and GA-1 A3 promoters.
At present, it is unknown whether a p4-dependent repression of the A2c
promoter, as described for
29, also applies for the equivalent A2c
promoters of Nf/B103 or GA-1. The fact that a typical p4 binding site
is lacking upstream of the A2c promoters of B103 (163), Nf
(158), and GA-1 (111) may be an indication
that p4 is not involved in the repression of these promoters, at least not in a similar way to that in
29. It is also unknown whether protein p6 of B103/Nf and/or GA-1 plays a role in the regulation of the
A2c, A2b, and A3 promoters of these phages.
Early Promoter C2: Transcriptional Regulation by Protein p6
All three phage genomes contain an early-expressed operon
located at the right end of their genome, whose expression is under the
control of the C2 promoter (Fig. 2). For
29 it has been demonstrated that the activity of the early promoter C2 decreases rapidly 10 min
after infection (110, 122, 149). Protein p6 was shown to be responsible for in vivo and in vitro repression of promoter C2
(14, 219). Thus, the
29 p6 protein not only plays a
role in the regulation of the A3, A2b, and A2c promoters (see above) but also regulates the expression of the C2 promoter. In addition, as
described below, it plays an important role in the initiation of
29
DNA replication. Most probably, binding of p6 to the DNA ends prevents
the RNA polymerase to recognize the C2 promoter (A. Camacho and M. Salas, unpublished results). The
29 mutant sus6(626)
contains a suppressible mutation in gene 6, and therefore protein p6 is
not synthesized in nonsuppressor cells infected with this mutant phage.
When
29 sus6(626) mutant phage was used for infection,
phage DNA replication did occur in suppressor cells but not in
nonsuppressor cells (219). However, under these conditions the C2
promoter was not repressed in either nonsuppressor or suppressor cells.
It appeared that whereas the amount of p6 protein synthesized under
permissive conditions was sufficient to permit in vivo
29 DNA
replication, it was too small to repress the C2 promoter in vivo
(47, 219). The observation that a fairly large amount of
p6 is required for repression of the C2 promoter in vitro (14, 219) supports this view.
Equivalent C2 promoters are also present in the genomes of B103 and
GA-1. Like the C2 promoter of
29, the GA-1 C2 promoter is expressed
almost exclusively during the first 10 min after infection (Horcajadas,
unpublished). In vitro expression of the C2 promoter of GA-1 is
inhibited in the presence of purified GA-1-encoded protein p6, as well
as, although somewhat less efficiently, by protein p6 of
29. DNase I
footprint analysis indicated that DNA binding of protein p6 prevents
the RNA polymerase from recognizing the C2 promoter of GA-1
(Horcajadas, unpublished results). Thus, due to protein p6-mediated
repression, the
29 and GA-1 C2 promoters are expressed only during
the initial 10 min after infection. Obviously, this repression will
limit the amount of proteins encoded by the downstream genes and ORFs.
Early Promoters C1, C1a, and C1b Present in
29,
B103, and GA-1, Respectively
All three phage genomes contain a promoter within the early
operon located at the right side of their genome (Fig. 2 and
Table 4). The absence of potential transcriptional terminators upstream of these promoters suggests that the last genes or ORFs of these operons may be expressed from two promoters. In
29 this
additional promoter was named C1. It is located within gene 16.7 and
may drive the expression of ORFs 16.6 and 16.5. In B103, the promoter is located within ORF d and may drive the expression of gene 16.7 and
ORF 16.5. According to the
29 nomenclature, this promoter of B103
was named C1 (163). Finally, in GA-1 the promoter is located within ORF G and may drive the expression of ORFs H to L. Since
these promoters drive the expression of different genes and ORFs, they
are not equivalent. Therefore, we named these promoters of B103 and
GA-1 Cla and Clb, respectively.
In vitro transcription analysis showed that expression of the
29 C1
promoter is repressed by protein p6 (14). Although p6
repressed the C2 promoter in the presence of low and high salt concentration, p6 affected C1 expression only at low salt
concentrations. This difference may be due to the higher affinity of p6
for the terminal
29 DNA fragment containing the C2 promoter than for the more internal DNA sequences containing the C1 promoter
(14).
Promoter A1, Driving Synthesis of the pRNA
For
29 it has been demonstrated that packaging of TP DNA into
the phage prohead requires a 174-base
29-encoded RNA (pRNA) (5, 93, 94). This pRNA is produced from promoter A1
(136, 137, 197), which is active throughout the infection
cycle (149). Although substantial levels of pRNA were
detected at early infection times, a rapid increase in the number of
pRNA molecules was detected starting about 15 min after infection,
which approximately coincided with the onset of
29 DNA replication.
Therefore, the additional phage DNA templates produced explain this
increase of pRNA and suggest a constant transcription rate
(149).
Equivalent A1 promoters driving pRNA synthesis of the corresponding
phages are present in B103 and GA-1 (Table 4). The pRNA coding
sequences of
29 and B103 are located at the far-left ends of their
genomes. Figure 2 shows that the situation is different for GA-1. This
genome contains an additional operon downstream of the
pRNA-coding region, as well as another operon located between gene 2 and its pRNA-coding region. A promoter is located upstream each
of these two unique operons. Thus, whereas the leftmost region of the
29 and B103 genomes contains only one promoter, this region of GA-1 contains three promoters. To maintain a consistent
nomenclature, the GA-1 promoter upstream of ORF M was named A1a, the
one driving the expression of the GA-1 pRNA was named A1b, and the one
upstream of ORF P was named A1c.
The expression patterns of GA-1 promoter A1b and B103 promoter A1
during the infection cycle have not been studied. Table 4 shows that
the
35 and
10 sequences of the A1 promoters of
29 and B103 and
the equivalent A1b promoter of GA-1 are almost identical and very close
to the consensus sequence recognized by
A-containing RNA
polymerase. Therefore, it is likely that the A1b promoter of GA-1 and
the A1 promoter of B103 behave similarly to the equivalent A1 promoter
of
29.
Other Promoters in the
29 Genome
In vivo and in vitro experiments revealed two promoters, named B1
and B2, that are located in the
29 DNA region encoding the late
genes (16, 197) (Fig. 2). Transcription from these promoters proceeds leftward. Compared to other
29 promoters, only
minor amounts of RNA were synthesized by the B1 and B2 promoters in
vivo (149). No ORF with a reasonable ribosome binding site was found downstream of either of these promoters. Although it has been
suggested that the products synthesized by these promoters may function
as antisense RNA to modulate the expression of some late genes
(16, 136), such a function has not been proven
experimentally. The
29 promoter A1IV, located in the DNA polymerase
coding region (Fig. 2), was shown to be weakly expressed in vivo
(16) and to contribute to the synthesis of protein p1
(40). The B1, B2, and A1IV promoters are shown in Table 4.
Other Promoters in the GA-1 Genome
The promoters A1c and A1a are unique for GA-1. Primer extension analysis using total RNA isolated at different times after infection showed that these two promoters are active early after infection and that they are progressively downregulated at later infection times (J. A. Horcajadas, unpublished). Therefore, it is likely that promoters A1c and A1a drive the expression of the GA-1 regions containing ORFs P to T and M to O, respectively. At present, the mechanism underlying the in vivo repression of these promoters is unknown. Since the pattern of repression of these promoters is different from that of the abruptly repressed C2 promoter, it is unlikely that these promoters are repressed by protein p6 in a similar way to the C2 promoter.
TRANSCRIPTIONAL TERMINATION
|
|
|---|
The main early and late in vivo transcription termination sites of
29 have been determined by S1 nuclease mapping (17). Transcription of the late A3 promoter and that of the early promoters C2 and C1 terminated in the short intergenic region between gene 16 and
ORF 16.5 (Fig. 2). This DNA region contains an inverted repeat, and
stem-loop structures with calculated free energies of
14.8 and
16.8
kcal could be drawn for the early and late transcripts, respectively.
In both directions, a uridine-rich tail follows the stem-loop,
indicating that it functions as a Rho-independent bidirectional
transcription terminator. This terminator was named TD1. Inverted
repeats are located at similar positions in the genomes of B103 and
GA-1. As in
29, uridine-rich tails at either strand follow the
stem-loops of B103 and GA-1, indicating that these also constitute
bidirectional Rho-independent transcriptional terminators. According to
the
29 nomenclature, these terminators were named TD1. The DNA
sequences of the TD1 terminators are shown in Table
5.
|
Another Rho-independent transcriptional terminator, named
TA1, was found to be present within gene 4 of
29 (17).
It has been suggested that part of the transcripts initiated at the A2b and A2c promoters terminate at this terminator. This would result in
the synthesis of high levels of mRNA coding for proteins p6 (DBP)
and p5 (SSB) and lower levels of longer mRNA coding for proteins p6
to p1 (17). Apart from possible differences in translation initiation efficiencies, this explains why p6 and p5 are synthesized in
far larger quantities than are proteins p4, p3, p2, and p1 (2,
86, 139). Equivalent TA1 transcriptional terminators are present
in the genomes of B103 and GA-1, indicating that a regulatory mechanism
similar to that proposed for
29 exists in B103 and GA-1. In all
three genomes, the TA1 transcriptional terminator is located at very
similar positions within gene 4. Thus, the mRNAs synthesized up to
the TA1 terminators may allow the synthesis of the N-terminal 28 to 30 amino acids of protein p4. Interestingly, this region of the three p4
proteins is far more conserved than the downstream p4 region (Fig.
3), which might imply that the N-terminal
30 amino acids of p4 could have a function on its own.
|
No potential Rho-independent transcriptional terminator is present
downstream of the pRNA coding region of
29, which constitutes the
most leftward-reading region of this genome (Fig. 2). This could imply
that transcription, starting from the A2b, A2c, and A1 promoters,
continues until the left end of the genome is reached. It has indeed
been shown that in vivo transcription initiating at these
29
promoters reaches the very left end of the
29 DNA molecule as if the
RNA polymerase would run off the template (16, 17). The
same organization and the absence of a potential Rho-independent terminator downstream of the B103 pRNA-coding region suggests a similar
situation for B103.
The situation is different, however, for GA-1. As shown in Fig. 2,
three potential Rho-independent terminators are present in the left
part of the GA-1 genome. The one located closest to the left DNA end
(downstream of ORF T), named TA4, would terminate transcription
initiating at the A1c promoter of GA-1. The middle one, named TA3,
located downstream of the pRNA coding region, would terminate
transcription initiating from the GA-1 promoter A1b and possibly A1a.
The third one, named TA2, would terminate transcription initiating from
the GA-1 A2c and A2b promoters. Note that in contrast to the situation
in
29 and B103, the GA-1 terminator TA2 is located directly
downstream of gene 2. The
35 sequence of the GA-1 promoter A1a is
located within this terminator.
PROTEIN-PRIMED MECHANISM OF DNA REPLICATION
|
|
|---|
The genomes of the
29-like phages consist of a linear dsDNA
molecule of about 20 kb with a phage-encoded protein, TP, covalently attached at each 5' end. Genomes consisting of a linear dsDNA molecule
with a TP covalently linked to their 5' ends have also been found for
(i) other bacteriophages (e.g., the Streptococcus pneumoniae
and Escherichia coli phages Cp-1 and PRD1, respectively), (ii) animal viruses (e.g., adenoviruses), (iii) plasmids (e.g., S1 and
Kalilo), and (iv) bacteria (e.g., Streptomyces). In most of
these cases, initiation of DNA replication occurs via a so-called protein-priming mechanism (for reviews, see references 176, 178, and 181).
The in vitro mechanism of protein-primed DNA replication has been
studied in most detail for
29. The basic features of the protein-primed mechanism of DNA replication, based on the
29 system,
are outlined here. More detailed descriptions of the different steps
and the function of the proteins involved are given below. In addition,
it should be mentioned that although the main characteristics of protein-primed DNA replication are conserved, some minor differences with respect to the
29 mechanism have been observed in some cases, especially regarding the sliding-back step (see below). Figure 4 shows a schematic representation of in
vitro
29 DNA replication. Initiation of
29 DNA replication starts
with recognition of the origin of replication, i.e., the TP-containing
DNA ends, by a TP-DNA polymerase heterodimer. The virus-encoded protein
p6 forms a nucleoprotein complex that would help to open the DNA
ends (187), facilitating the formation of a covalent
linkage between the first inserted nucleotide (dAMP) and TP,
which is catalyzed by the
29 DNA polymerase (29, 109).
The formation of this first TP-dAMP covalent complex is directed by the
second nucleotide at the 3' end of the template; then the TP-dAMP
complex slides back 1 nucleotide to recover the information of the
terminal nucleotide (144). Next, the
29 DNA
polymerase synthesizes a short elongation product before dissociating
from the TP (146). Replication, which starts at both DNA
ends, is coupled to strand displacement. This results in the generation
of so-called type I replication intermediates consisting of
full-length
29 dsDNA molecules with one or more ssDNA branches of
different lengths. The ssDNA stretches generated are bound by the SSB
protein (p5). When the two converging DNA polymerases merge, a type I
replication intermediate becomes physically separated into two type II
replication intermediates. Each of these consists of a full-length
29 DNA molecule in which a portion of the DNA, starting from one
end, is double stranded and the portion spanning to the other end is
single -stranded (102, 117). Continuous elongation by the
DNA polymerase completes replication of the parental strand.
|
INITIATION OF DNA REPLICATION
|
|
|---|
DNA Polymerase-TP Heterodimer Formation
DNA polymerases are unable to initiate de novo DNA synthesis on a
DNA template but require the existence of a primer containing a free
hydroxyl group to start DNA elongation (126). Generally, RNA primers provide the 3'-hydroxyl (3'-OH) group needed by the DNA
polymerase to elongate the DNA chain. However, in most linear genomes
containing a TP covalently linked to their 5' DNA ends, the 3'-OH group
of a specific serine, threonine, or tyrosine residue of the TP is used
for DNA elongation (reviewed in reference 181). In
29
DNA polymerase, its TP deoxynucleotidylation activity is responsible
for the covalent linkage of 5'-dAMP, via a phosphoester bond, to the
hydroxyl group of Ser232 of the TP (24, 29,
109). This reaction requires the formation of a stable
heterodimer complex between the TP and the
29 DNA polymerase
(28). Most probably, the active site used for
polymerization is also used for the TP deoxynucleotidylation reaction
(reviewed in references 31 and 32). This implies that the
TP present in the heterodimer complex has to be specifically positioned
in order for the DNA polymerase to perform the TP deoxynucleotidylation reaction. Several mutations located in different regions of the
29
DNA polymerase affect its interaction with the TP (37, 61, 145,
206). In addition, interaction of TP with the purified C-terminal portion of the
29 DNA polymerase is severely impaired (209). Together, these results suggest that interaction of
the TP involves many contacts with different regions of the DNA polymerase.
Interestingly, a multiple sequence alignment of DNA polymerases
belonging to the B-type family showed that DNA polymerases involved in
protein-primed DNA replication contain two regions of amino acids,
denoted TPR-1 and TPR-2 (Fig. 5), which
are not present in other B-type DNA polymerases (33).
Analysis of the
29 mutant DNA polymerase in which the conserved
Asp332 residue of the TPR-1 region was changed into Tyr
showed that it was able to form a stable heterodimer with TP and that
it had essentially wild-type levels of synthetic activities in DNA
primed reactions. However, its activity was drastically affected in
29 TP-DNA replication, indicating that the mutant DNA polymerase forms a non functional interaction with the TP and hence supporting the
view that at least TPR-1 is involved in proper positioning of the TP in
the TP-DNA polymerase heterodimer complex (68).
|
Sliding-Back Mechanism
Although the TP deoxynucleotidylation reaction can occur in the
absence of a DNA template, it is strongly stimulated in the presence of
29 TP-DNA (24). In the latter case, TP-dAMP
is preferentially formed. The DNA ends of
29 have a short inverted terminal repeat of 6 nucleotides (3'-TTTCAT-5'). The first TP-dAMP is
not directed by the terminal nucleotide but by the penultimate nucleotide of the
29 template strand. Subsequently, the complex slides back 1 nucleotide to recover the information of the 3'-terminal nucleotide (144). Terminal repeats are also present in the
genomes of B103 (3'-TTTCAT-5'), GA-1 (3'-TTTATCTT-5'), and all other
29-related phages analyzed so far. Moreover, this feature is also
conserved in other linear genomes containing a TP covalently linked to
their DNA ends, such as the E. coli and S. pneumoniae phages PRD1 and Cp-1, respectively, linear plasmids,
and the eukaryotic adenovirus. Terminal reiteration is a prerequisite
for the sliding-back mechanism. Indeed, the replication initiation site
in GA-1 (114), PRD1 (43), Cp-1
(132), and adenovirus (125) corresponds to an
internal nucleotide close to the 3'-terminal end, and a sliding-back or similar mechanism has been shown to occur in these cases to recover the
information of the terminal nucleotide(s). Probably, the sliding-back mechanism applies to all genomes that replicate via a protein-primed mechanism. Since proofreading does not apply to the TP-dNMP product (72), the sliding-back mechanism would be an alternative
way to ensure that the replication origin-containing DNA ends are replicated with high fidelity.
Transition from Protein-Primed to DNA-Primed Replication
After the sliding-back step, the
29 DNA polymerase and the
primer TP do not dissociate immediately. Rather, there is a transition stage in which the DNA polymerase synthesizes a DNA molecule of 5 nucleotides while complexed with the primer TP (initiation mode). During the synthesis of nucleotides 6 to 9 the complex undergoes some
structural change (transition mode), and the DNA polymerase finally
dissociates from the primer TP when the nucleotide 10 is inserted into
the nascent DNA chain (elongation mode) (146). This
behavior probably reflects a requirement of the
29 DNA polymerase for a DNA primer of a minimum length to efficiently carry out DNA-primed elongation. This view is supported by the following data.
First, Méndez et al. (146) demonstrated that primer
molecules of 6 nucleotides or less are not elongated. This fits well
with the observation that
29 DNA polymerase synthesizes a DNA chain of 5 nucleotides before it changes from the initiation mode to the
elongation mode in TP-DNA-primed reactions. Second, abortive replication products consisting of the primer TP linked up to 8 nucleotides were particularly observed under conditions that decrease
the strand displacement capacity of
29 DNA polymerase (146). Finally, de Vega et al. (62)
demonstrated that
29 DNA polymerase covers a DNA region of 10 nucleotides, which may be indicative of the optimum length to carry out
polymerization. Interestingly, the
29 DNA polymerase mutant in which
Asp456, belonging to the conserved "YxDTDS" motif at
the polymerization domain (see below), has been changed into Gly is
unable to proceed further than 5 nucleotides from the initiation
complex. This suggested that the
29 DNA polymerase residue
Asp456 is crucial to entry into the transition stage of
29 DNA replication (185).
A similar transition step has also been demonstrated in replication of adenovirus (124) and probably is a general feature of protein-primed DNA replication.
THE FOUR MAIN PROTEINS REQUIRED FOR IN VITRO DNA
REPLICATION
|
|
|---|
In the
29, B103, and GA-1 genomes, genes 6, 5, 3 and 2 are
located in a single early-expressed operon (Fig. 2). In
29,
these genes are indispensable for in vivo phage DNA replication. Gene 2 encodes the DNA polymerase, gene 3 encodes the TP, gene 5 encodes SSB,
and gene 6 encodes DBP. An in vitro
29 DNA replication system, based
on these four purified proteins, has been established
(27). The availability of this system has allowed a
detailed analysis of the in vitro
29 DNA replication mechanism and
functional analysis of these four main replication proteins.
Characteristics of these four proteins are given below.
DNA Polymerase
Gene 2 of
29, B103, and GA-1 encodes a DNA polymerase. In
29
and GA-1 the DNA polymerase has been shown to be required for replication of its phage DNA (29, 114). The DNA
polymerases encoded by
29, B103, and GA-1 belong to the B-type
superfamily of DNA-dependent DNA polymerases (also referred to as
eukaryotic or
-like polymerases). This family includes a large
number of prokaryotic and eukaryotic enzymes that are sensitive to
certain drugs (aphidicolin and phosphonoacetic acid) and nucleotide
analogs (butylanilino-dATP and butylphenyl-dGTP). The DNA polymerase of
29 has been analyzed in detail (for reviews, see references 31 and
32). The monomeric
29 DNA polymerase, which has a size of only about
66 kDa, catalyzes both the initiation and elongation stages of DNA
synthesis (29, 30). To accomplish this, it is able to
carry out two distinguishable synthetic reactions: TP deoxynucleotidylation and DNA polymerization. In addition, it has two
degradative activities: pyrophosporolysis and 3'-5' exonucleolysis. Moreover, it has two intrinsic properties: high processivity and strand
displacement ability (25). Due to the
29 DNA polymerase properties, in vitro
29 DNA replication does not require accessory proteins and DNA helicases (25).
The enzymatic activities of the
29 DNA polymerase have been mapped
by site-directed mutagenesis. A structural map, given in Fig. 5, shows
that the
29 DNA polymerase has a bimodular organization, with the
N-terminal portion constituting the 3'-5' proofreading domain and the
C-terminal portion constituting the domain responsible for its 5'-3'
synthetic activities. The bimodular organization of the
29 DNA
polymerase has been proven experimentally. Analysis of a purified
C-terminal deletion derivative of
29 DNA polymerase containing the
188 N-terminal amino acids showed that it was devoid of any synthetic
activity but retained 3'-5' exonuclease activity (31).
Reciprocally, a purified N-terminal deletion derivative containing the
C-terminal 388 amino acids had neither 3'-5' exonuclease nor strand
displacement activity but did have synthetic activities (209). Available three-dimensional structures of other DNA
polymerases show that the bimodular organization is characteristic of
proofreading proficient DNA polymerases (reviewed in reference 121).
C-terminal domain of
29 DNA polymerase.
The
polymerization activity of the
29 DNA polymerase is confined to the
C-terminal domain of the enzyme. This part of the
29 DNA polymerase
has three regions containing motifs that are conserved in other DNA
polymerases belonging to family B. These three motifs are
Dx2SLYP (motif A, also named motif 1), Kx3NSxYG (motif B, also named motif 2a), and YxDTDS (motif C, also named motif
3). The positions of these and other conserved motifs described below
are indicated in Fig. 5, together with the amino acid sequence corresponding to each motif present in the DNA polymerase of
29, B103, and GA-1. Site-directed mutagenesis at motifs A, B, and C of
29 DNA polymerase (21, 34-36) showed that these three
regions form an evolutionarily conserved polymerization-active site.
29
Leu253. Analysis of a
29 DNA polymerase mutant in which
Leu253 had been replaced by a Val residue (L253V) showed
that whereas it was not affected in template-primer DNA binding, it was
strongly affected in reactions involving the use of TP as primer
(35). With this result in mind, it would be interesting to
study the effects of a
29 L253M DNA polymerase mutant and relate it
to the reciprocal mutation in the GA-1 DNA polymerase (M253L). For motif B, the residue corresponding to Asn387 of
29 DNA
polymerase is occupied by an Asp in the B103 polymerase (Fig. 5). The
involvement of
29 DNA polymerase Asn387 in the correct
binding of the primer terminus at the polymerization active site was
demonstrated by the analysis of the N387Y mutant (36).
Taking into account the protein sequence of the B103 DNA polymerase, it
would be interesting to study possible effects of replacing
Asn387 by Asp (N387D).
In addition to motifs A, B and C, two other motifs, Tx2GR
(motif 2b) and KxY (motif 4), were identified in the C-terminal portion
of
29 DNA polymerase and analyzed by site-directed mutagenesis (37, 145). These two motifs, which are also conserved in
the C-terminal portion of B103, GA-1 (Fig. 5), and other B-type DNA polymerases, are involved in primer stabilization at the active site.
In addition, motif 2b is involved in TP and metal binding (145). For several DNA polymerases, including the
29
DNA polymerase, it has been demonstrated that three Asp residues form a
metal binding triad required for catalysis at the polymerization active site (reviewed in reference 32). In the
29 DNA polymerase, the three
Asp residues implicated are Asp249, belonging to motif A,
and Asp456 and Asp458, both belonging to motif
C (21, 35, 185). These three Asp residues are conserved in
the DNA polymerases of B103 and GA-1 and in all other known members of
the B-type DNA polymerases. Also, Arg438 of motif 2b of
29 DNA polymerase plays a role in catalysis of the polymerization
reaction (145). Moreover, three highly conserved Tyr
residues were shown to be involved, directly or indirectly, in
interaction with deoxynucleoside triphosphates (dNTPs). These residues,
also conserved in the B103 and GA-1 DNA polymerases (Fig. 5), are
Tyr254 of motif A (34, 35), Tyr390
of motif B (34, 36), and Tyr454 of motif C
(21). Since the
29 residues Tyr254 (motif
A) and Tyr390 (motif B) are also involved in selection of
dNTP binding, they play an important role in the fidelity of DNA
replication (184). In addition, a single and specific
replacement of Tyr254 (motif A) by a Val residue enables
the mutant
29 DNA polymerase to incorporate ribonucleotides without
affecting its wild-type affinity for dNTPs (38). This
indicates that
29 Tyr254 is responsible for the
discrimination against the 2'-OH group of an incoming ribonucleotide.
In addition, seven residues that are invariant or highly conserved in
the C-terminal domain of B-type DNA polymerases were shown to be
involved in binding template-primer structures. These residues are
Ser252 of motif A (35), Asn387
(see above) and Gly391 of motif B (36),
Thr434 and Arg438 of motif 2b
(145), and Lys498 and Tyr500 of
motif 4 (37).
N-terminal domain of
29 DNA polymerase.
(i)
Proofreading.
The insertion discrimination values of the
29 DNA
polymerase range from 104 to 106 and the
efficiency of mismatch elongation is 105- to
106-fold lower compared to a properly paired terminus
(72). These values illustrate the high fidelity with which
the
29 DNA polymerase replicates DNA. As with other
proofreading-proficient DNA polymerases, the
29 DNA polymerase owes
its high fidelity to its 3'-5' exonuclease activity (81),
which is confined to the N-terminal part of the enzyme. Bernad et al.
(20) proposed that three N-terminally located regions,
ExoI, ExoII, and ExoIII, form the 3'-5' exonuclease active site (Fig.
5) and are evolutionarily conserved in prokaryotic and eukaryotic DNA
polymerases. This proposal has been proven valid for various DNA
polymerases of eukaryotic and prokaryotic origin (for a review, see
reference 60). The three Exo domains contain five invariant residues
that are involved in metal binding and 3'-5' exonuclease catalysis. In
29 DNA polymerase, these residues are Asp12 and
Glu14 in ExoI, Asp66 in ExoII, and
Tyr165 and Asp169 in ExoIII (20).
29 DNA polymerase and can be extrapolated to other
proofreading-proficient DNA polymerases (73). Another
invariant residue, Lys143 of
29 DNA polymerase, was
analyzed and shown to be important for the catalytic efficiency of the
3'-5' exonuclease activity (63). In addition, other
residues in the Exo motifs that are conserved in B103, GA-1, and most
other prokaryotic and eukaryotic DNA polymerases were functionally
analyzed. Two of these, Thr15 and Asn62,
located at the ExoI and ExoII motifs, respectively, were shown to act
as single-stranded DNA ligands playing a critical role in the
stabilization of the frayed primer terminus at the 3'-5' exonuclease
active site (64). Also, Phe65 of the ExoII
motif and residues Ser122 and Leu123, which are
part of a newly identified motif [S/T]Lx2h, were shown to
be important for (i) stable interaction with ssDNA, (ii) 3'-5' exonucleolysis of ssDNA substrates, and (iii) proofreading of DNA
polymerization errors (65). In addition, these studies
showed that the aromatic ring of Phe65 appeared to be
critical to orient the ssDNA substrate in a stable conformation to
allow 3'-5' exonucleolytic catalysis. These three residues,
Phe65, Ser122, and Leu123, are also
conserved in the B103 and GA-1 DNA polymerases.
(ii) Strand displacement.
After the initiation,
sliding-back, and transition steps, continuous polymerization, carried
out by a single
29 DNA polymerase molecule, completes the
replication of the almost 20-kb DNA strand (30). Using
primed M13 DNA as the template, the
29 DNA polymerase is able to
synthesize DNA chains of more than 70 kb (25). This demonstrates the high processivity and strand displacement activity of
the
29 DNA polymerase. Replication of
29 DNA starts
nonsimultaneously from either end of the linear DNA molecule
(117), generating so-called type I replication
intermediates (Fig. 4). Until the two converging DNA polymerases
collide, DNA polymerization is coupled to strand displacement, which
makes a helicase unnecessary (25). Various DNA
polymerases, but not the one encoded by
29, are prone to replication
slippage. This particular type of error, which results in deletions, is
caused when a polymerizing DNA polymerase slips between two short
sequence duplications. Recently, evidence has been presented that the
high strand displacement activity of the
29 DNA polymerase prevents
replication slippage (48).
29 DNA polymerases
containing mutations in one of the five invariant residues in the Exo
motifs critical for 3'-5' exonuclease activity, Asp12,
Glu14, Asp66, Tyr165, or
Asp169, showed that they were also strongly affected in
their strand displacement activity (73, 194). In addition,
mutants corresponding to Lys143, the residue which is
conserved in GA-1 and B103 DNA polymerases and was shown to play an
auxiliary role in catalysis of the exonuclease reaction, were affected
in strand displacement activity (62). These results
indicated that the strand displacement activity of
29 DNA polymerase
is located in its N-terminal domain, somehow overlapping with the
3'-5'exonuclease activity.
Mutations of residues Thr15 and Asn62, shown to
act as ssDNA ligands but not playing a direct role in the
29 DNA
polymerase 3'-5' exonuclease catalysis reaction, displayed wild-type
levels of strand displacement activity (64). Therefore, it
seems that impaired strand displacement activity is restricted to the
3'-5' exonuclease mutants that act directly as metal ligands or to
those that affect the metal binding network. Based on these results, it
was proposed that contacts with divalent metal ions assist in
interactions with the displaced ssDNA strand (32).
Coordination between synthesis and degradation.
As
described above, the
29 DNA polymerase has a bimodular organization,
with its degradative and strand displacement activities present in the
N-terminal domain and the synthetic activities present in the
C-terminal domain. Effective proofreading of a DNA polymerization error
therefore requires that the primer terminus containing the error switch
intramolecularly from the polymerization to the 3'-5' exonuclease
active site (62). A conserved motif, YxG[G/A], located
between the proofreading and polymerization domains (Fig. 5, indicated
by CT for cross talk; note that this motif is also conserved in the DNA
polymerases of GA-1 and B103) was recently shown to play an important
role in the coordination between DNA synthesis and proofreading
(208). Single amino acid substitutions in this motif of
29 DNA polymerase gave rise to three different mutant phenotypes:
(i) favored polymerization, (ii) favored 3'-5' exonucleolysis, or (iii)
favored 3'-5' exonucleolysis with loss of polymerization. The different
phenotypes could be directly related to defects in DNA binding at
either active site, thereby stimulating the activity of the other
active site. Thus, the YxG[G/A] motif exerts its important role in
the coordination between synthesis and degradation primarily through
DNA binding.
Terminal Protein p3
The initiation of protein-primed DNA replication requires the
formation of a stable heterodimer complex between the TP and the DNA
polymerase. Several lines of evidence indicate that the TP occupies the
double-stranded DNA binding channel in the DNA polymerase during
initiation of replication. First, mutant
29 DNA polymerases that are
affected in interaction with TP also show a reduced capacity to bind a
DNA template-primer structure (37, 61, 145, 206). Second,
partial proteolysis of the
29 DNA polymerase-TP heterodimer with
endoproteinase LysC resulted in a protection and digestion pattern
similar to that obtained with DNA (207). Finally, binding
of TP to
29 DNA polymerase prevents binding and polymerization on
DNA template-primer structures (61). Stable heterodimer
formation involves many contacts with different regions of the
29
TP, as shown for the
29 DNA polymerase. These include (i) an
internal region near the N terminus (amino acids 72 to 80)
(228), (ii) the C-terminal region (amino acids 242 to 262)
(228), and (iii) the RGD motif located at positions 256 to
258 in
29 TP (116). It should be noted that although the RGD motif is conserved in most other Bacillus
phage-encoded TPs (including the one encoded by B103), it is not
conserved in the TP of GA-1.
In most linear genomes a TP molecule is covalently linked to the 5' DNA
ends. In
29 the 5'-terminal dAMP is linked via a phosphoester bond
to the hydroxyl group of Ser232 of the TP
(109). The observation that a mutant
29 TP in which Ser232 was replaced by a Thr residue had completely lost
its priming activity illustrated the high specificity of
Ser232 (82). The Ser232 residue of
the
29 TP is conserved in the TPs encoded by B103 and GA-1. Although
experimental evidence is lacking, this suggests that the hydroxyl group
of the conserved Ser residue is used for the linkage of the first dAMP
in B103 and GA-1 as well.
The DNA ends containing the attached TP molecule constitute the origins of replication. The first step of initiation of DNA replication is the recognition of these origins by a TP-DNA polymerase heterodimer. The TP molecule in the heterodimer functions as primer for the subsequent replication initiation step. To discriminate between the two different functions, the TP molecule linked to the 5' DNA ends is called parental TP and the TP present in the complex with DNA polymerase is called primer TP.
Blunt-ended DNA fragments containing the left or right
29 DNA ends,
but not internal
29 DNA fragments, were active as templates in in
vitro initiation reactions (80, 103, 104). On
one hand, this indicated that specific DNA sequences located at the
29 DNA ends are involved in origin recognition, and on the other hand it suggested that the TP has DNA binding affinity. The latter feature was indeed demonstrated, and amino acids 13 to 18, 30 to 51 and
56 to 71, all located in the N-terminal portion of the
29 TP, were
shown to be involved in DNA binding (228).
Although blunt-ended DNA fragments comprising the left or right
29
DNA ends were active in in vitro initiation reactions, their activity
was far lower than that of DNA ends containing a parental TP
(103, 104). These results showed that the parental TP is
the major signal in the template for origin recognition and strongly
suggested that the TP-DNA polymerase heterodimer is recruited to the
origin through interaction with the parental TP. The observation that
parental TP molecules can interact with each other (159,
179) suggests that recruitment of the heterodimer to the origin
is brought about by protein-protein contacts between the parental and
primer TP. The
29 TP residues Asn80 and
Tyr82, which are conserved in other Bacillus
phage-encoded TPs including those of B103 and GA-1, were shown to be
specifically involved in this recruitment (115).
Interestingly, these residues are located just before a region,
spanning amino acids 84 to 118, that has a high probability of forming
an amphipathic
-helix, which might provide an appropriate surface
for the interaction between parental and primer TP through the
formation of a coiled coil. This putative amphipathic
-helix is
conserved in all other TPs encoded by
29-like phages. Recently,
evidence has been presented that this putative coiled-coil domain of
29 TP is indeed an important element for origin recognition
(186). In addition to interactions between primer and
parental TP, it has been shown that origin recognition also involves
interactions between the DNA polymerase and the parental TP
(87).
DBP Protein p6
The DBP protein p6, which has been described as a histone-like
protein (187), is able to bind in vitro to the whole
29
DNA, and a role in genome organization has been proposed
(100). Its specific role in regulating the expression of
the
29 promoters A2b, A2c, A3, and C2 is described above. The high
intracellular abundance of p6 in infected cells suggests that it also
plays a role in
29 genome organization in vivo (2,
187). Although the large amounts of p6 synthesized in infected
cells are sufficient to bind the whole
29 DNA, it binds
preferentially at the DNA ends (167, 189) through the
minor groove (77, 190). The preferred protein p6 binding
sites are located at nucleotides 46 to 68 and 62 to 125 at the left and
right
29 DNA ends, respectively. Whereas these regions do not show
sequence similarity, they do contain DNA sequences that are predicted
to be bendable every 12 bp (189), and this feature was
indeed shown to be the major determinant for protein p6 recognition
(188). Interestingly, the
29 DNA region containing
promoters A2b and A3 has intrinsic curvature (143, 173),
which may be important for protein p6 binding and thus for its role in
regulation of these promoters.
Protein p6 was shown to be essential for in vivo
29 DNA replication
(50, 70). Binding of protein p6 to the DNA ends activates initiation of
29 DNA replication (26, 180). When
protein p6 binds to circular DNA, it restrains positive supercoiling,
supporting a model in which a right-handed superhelix of DNA wraps
tightly around a multimeric protein p6 core (190). It was
indeed demonstrated that the
29 DNA ends adopt a right-handed
toroidal conformation that wraps around a multimeric p6 core
(188). On protein p6 binding, the DNA is compacted
4.2-fold. The parameters that define the path taken by the DNA in the
protein p6 complex have been defined: one superhelical turn has 63 bp
with a pitch of 5.1 nm and a diameter of 6.6 nm. Consequently, the DNA
should be strongly bent (66° every 12 bp) and underwound (11.5 bp/turn) (188). The specific conformation of this
nucleoprotein complex would help to open the DNA ends (180,
188), facilitating the formation of the covalent linkage between
dAMP and the primer TP catalyzed by
29 DNA polymerase.
A deletion derivative lacking the N-terminal 13 amino acids of
29
protein p6 is unable to bind DNA, indicating that this region of p6 is
involved in DNA binding (160). Secondary-structure predictions indicated the existence of a putative amphipathic
-helix
in this region. To test the possibility that the positively charged
residues of this putative helix are involved in DNA interaction, the
Lys2 and Arg6 residues were changed into Ala.
The observation that both purified mutant p6 proteins were affected in
DNA binding supported this hypothesis (77). Also the
N-terminal regions of the p6 proteins encoded by B103 and GA-1 are
predicted to form an
-helix with an amphipathic character. In
addition, the two positively charged residues of the
29 protein p6
that are important for DNA binding are conserved in the p6 proteins
encoded by B103 and GA-1. These conserved sequence features in the
N-terminal part of the various p6 proteins may reflect a conserved
function for this region, i.e., its involvement in DNA binding.
The
29-protein p6 was shown to form dimers in solution
(162). Self-association of
29 protein p6 was studied in
more detail using analytical ultracentrifugation analysis
(2). In these studies it was shown that in the absence of
DNA and in a concentration range between 1 and 100 µM, protein p6 is
in a monomer-dimer equilibrium, in agreement with earlier studies.
However, at concentrations around 1 mM, which corresponds approximately
to the intracellular concentration of p6 in infected cells, protein p6
associates into oligomers (2). These results further
supported the view that protein p6 can form a scaffold for DNA binding.
In subsequent studies the structure of the oligomers were analyzed by
transmission electron microscopy. This revealed that protein p6
aggregates into crooked oligomers, compatible with a helical structure
(1).
Residues of
29 protein p6 that were critical for self-association of
the protein were identified by random mutagenesis (3). The
mutations found were mainly clustered in two regions, one located at
the N terminus and the other located in the central part of the
protein. Two
29 p6 single mutants, A44V and I8T, were further
analyzed. These mutants showed, in addition to impaired dimer formation
ability, reduced DNA binding affinity; consequently, they were also
affected in activation of in vitro initiation of
29 DNA replication.
These two residues of the
29 protein p6 are conserved in the p6
proteins of B103 and GA-1. Dimer formation capacity was enhanced in
protein
29 p6 mutants containing C-terminal deletions. In these
latter mutants, a highly acidic region, which is conserved in the p6
proteins of GA-1 and B103, was removed, and hence it was proposed that
this C-terminal acidic region modulates
29 protein p6
self-association (3).
Protein p6 binds with a precise phase to the replication origins of
29 DNA, which is crucial for the activation of DNA replication (190). Thus, protein p6 did not activate a DNA fragment
with a 4-bp insertion between the nucleation and the initiation site because the p6 binding was out of phase with respect to the replication origin. Restoring the p6 binding phase by the insertion of 24 bp
resulted in recovery of the replication initiation activity (190). The phasing of protein p6 encoded by GA-1 and Nf
(the latter belonging to the B103 group of
29-related phages) on
homologous and heterologous DNAs was studied by hydroxyl radical and
DNase I footprinting analyses (78). The p6 proteins of Nf
and B103 are 95% identical. When tested in the presence of homologous
DNA, the periodicity of protection of the p6 proteins of
29 and Nf was 12 bp (corresponding to one monomer) and that of GA-1 was 11 bp.
Similar protection assays using heterologous DNA showed that the
periodicity and positioning of the Nf protein p6 monomers on
29 DNA
was almost the same as for those formed by
29 protein p6 on its
homologous DNA. However, in the reciprocal situation the protection of
29 protein p6 bound to Nf DNA was shifted 4 bp with respect to the
homologous Nf situation, indicating that Nf and
29 p6 proteins
recognized different signals in the Nf DNA. Thus, although the phasing
was not conserved, protein p6 of
29 and Nf are able to bind to the
respective heterologous DNA. A different outcome was observed for
protein p6 of GA-1. In this case, no clearly structured complexes of
GA-1 protein p6 were formed on
29 or Nf DNA, although these were
formed with GA-1 DNA. Moreover, Freire et al. (78) showed
that correct phasing of p6 with respect to the origins of replication
was required for activation of GA-1 and Nf DNA replication, as observed
for
29. These studies nicely illustrated, on one hand, that the
protein p6 mechanism of DNA replication activation is conserved for
29, Nf, and GA-1 and, on the other hand, that each of the three p6 proteins forms highly specific structures with their respective DNA
origins that are required for activation of initiation of DNA replication.
SSB Protein p5
Due to its symmetrical mode of DNA replication, coupled to strand
displacement, the replication intermediates generated during
29 DNA
replication contain large stretches of ssDNA. Gene 5 of phages
29,
B103, and GA-1 encodes an SSB that is highly abundant in infected
cells. The SSB protein p5 is essential for elongation of replication in
vivo (139). Direct binding of
29 protein p5 to
29
DNA replication intermediates has been demonstrated (101). This binding protects the ssDNA branches against nuclease degradation and greatly stimulates dNTP incorporation during
29 DNA replication in vitro (133). Because binding of protein p5 prevents
nonproductive binding of the DNA polymerase to ssDNA
(101), this probably explains the strong enhancement of
DNA replication by SSB. In addition, binding of p5 to ssDNA increases
the DNA elongation velocity about fivefold in in vitro
29 DNA
replication using
29 DNA polymerase mutants that are defective in
strand displacement. This effect is most probably due to the
helix-destabilizing properties of
29 SSB (196). Protein
p5 of
29 binds ssDNA in a cooperative way
(Keff = 105 M
1,
= 50 to 70), covering 3.4 nucleotides per p5 monomer
(85, 195).
The importance of SSB in replication is further illustrated in in vitro
29 DNA amplification assays. Omission of protein p5 from the
reaction mixtures results in the generation and amplification of short
29 DNA products (27). Esteban et al. (71)
have shown that such small
29 DNA products have a palindromic nature
and that they are caused by a DNA polymerase template-switching event. The presence of sufficient protein p5 prevents the DNA polymerase from
switching template by either one or both of the following two
mechanisms. First, binding of protein p5 to ssDNA may preclude the
displaced ssDNA strand from being an alternative template for the DNA
polymerase. Second, binding of SSB will prevent the formation of
secondary structures in the displaced ssDNA strand, which otherwise
impedes efficient progression of the DNA polymerase and which probably
stimulates the DNA polymerase to switch template (71).
Recently, comparative studies of the structural complexes formed by the
29, Nf, and GA-1 SSB with DNA have been performed (85).
The sequences of the Nf and B103 SSB are 96% identical. Whereas the
SSB of
29 and Nf formed stable monomers in solution under the
conditions used, the SSB of GA-1 formed hexamers. In addition, the GA-1
SSB occluded a larger binding site (51 nucleotides/hexamer) than did
the
29 and Nf SSBs (3.4 and 4.7 nucleotides/monomer, respectively).
Moreover, on binding, the GA-1 SSB compacted the ssDNA far more than
the
29 SSB did. Whereas the length of the ssDNA was reduced about
sixfold on binding of GA-1 SSB, only a twofold reduction was obtained
on binding of
29 SSB (85, 101). In addition to the
structural complexes formed between the SSB of
29, Nf, and GA-1,
their functional behavior has been analyzed recently (86).
In agreement with the structural analysis, far less GA-1 SSB than Nf or
29 SSB was required to display a helix-destabilizing effect and to
stimulate dNTP incorporation in in vitro DNA replication assays. In
summary, the SSB of GA-1 behaved structurally and functionally quite
differently from the SSBs of Nf and
29. Comparison of the three SSB
sequences showed that the SSB of GA-1 has an N-terminal extension of
about 40 amino acids. Possibly, this additional protein domain is
involved in the different characteristics of the GA-1 SSB.
OTHER GENES AND OPEN READING FRAMES DOWNSTREAM OF GENE 2 IN
29 AND B103
|
|
|---|
Figure 2 shows that a transcriptional terminator (TA2) is present
in the GA-1 genome downstream of gene 2, strongly indicating that genes
6 to 2 constitute one operon that is expressed by the GA-1
promoters A2b and A2c. In contrast, the corresponding operon of
29 contains, in addition to genes 6 to 2, gene 1 (86 codons) as well
as three ORFs, named ORF 1A, ORF 1B and ORF 1C, that may encode
proteins of 56, 58, and 47 amino acids, respectively. Also, the
corresponding operon of B103 contains four additional ORFs downstream of its gene 2. These ORFs, which we named ORF g, ORF h, ORF
i, and ORF j, may encode proteins of 36, 67, 56, and 22 amino acids,
respectively. The function of the putative small proteins encoded by
29 ORFs 1A to 1C and B103 ORFs g to j is yet unknown. It should be
mentioned, however, that the deduced protein sequence of B103 ORF h
shows significant similarity to the 46 C-terminal amino acids of
29
protein p1 (50 and 62.5% identity and similarity, respectively). In
addition, the deduced protein sequences of
29 ORF 1A and B103 ORF i,
both 56 amino acids long, have a high level of similarity (64 and 75%
identity and similarity, respectively). Finally, the deduced protein
sequence of B103 ORF j (22 amino acids) is similar to the N-terminal
part of
29 ORF 1B (50 and 59% identity and similarity,
respectively). These similarities suggest that the putative proteins
encoded by these ORFs may have similar functions.
Gene 1 of
29
The
29 sus1(629) mutant contains a point mutation
which changes codon 7 of gene 1 (CAA) into a nonsense TAA codon
(166). Compared to wild-type
29-infected cells, two
proteins with molecular masses of about 8.5 and 4.5 kDa were not
detected when nonsuppressor cells were infected with
sus1(629) mutant phage (8, 50). The 8.5-kDa
protein is most probably the product of gene 1. The absence of the
other protein may be due to either a polar effect or the presence of a
second mutation. Phage
29 DNA replication was severely affected in
sus1(629) phage-infected nonsuppressor cells when these were
grown at 37°C (41, 42, 166). However, when the infected
cells were grown at 30°C, the rate of sus1(629) DNA
synthesis was only slightly lower than in cells infected with wild-type
phage (42). These results showed that in vivo DNA synthesis of sus1(629) is affected in a
temperature-dependent manner. Protein p1 was found to be associated
with the cell membranes, and the 43 C-terminal amino acid residues are
required for membrane association (41). In addition,
purified protein p1 lacking its 33 N-terminal amino acid residues
assembled into long protofilaments that associated in a highly ordered,
parallel array forming large two-dimensional sheets (42).
Together with other data (41), these results suggested
that protein p1 is a component of a virus-encoded membrane-associated
structure which would provide an anchoring site for the viral DNA
replication machinery (41, 42). The observation that an
excess of p1 interferes with the in vitro
29 DNA replication
initiation reaction and that p1 interacts with the TP, as assessed by
in vitro cross-linking studies, supports this view (40).
Another function has been attributed to
29 protein p1 by Take-Uchi
et al. (199, 200). They found that larger amounts of
29
DNA polymerase were produced in nonsuppressor cells infected with
sus1(629) than in those infected with wild-type
29 phage (200). This indicated that protein p1 might down-regulate
the synthesis of the DNA polymerase. Experiments performed with
E. coli showed that in addition to the DNA polymerase, the
synthesis of TP (gene 3) and the transcriptional regulatory protein
(gene 4) was diminished by protein p1. Because similar levels of
mRNA encoding genes 4-1 were synthesized in the absence or presence of functional gene 1, protein p1 appeared not to affect the
transcription of these genes. The observation, however, that protein p1
was able to bind mRNA of genes 1 to 4 suggested that the observed repression might be at the translational level (199).
GA-1 OPERONS CONTAINING OPEN READING FRAMES M-O AND P-T
|
|
|---|
Surprisingly, a gene 1 homologue is not present in the genome of
GA-1. As described above, the GA-1 promoters A1c and A1a are expressed
early after infection. Therefore, it is likely that proteins are
synthesized from ORFs M to O and P to T. The deduced protein sequences
of none of these ORFs showed significant homology to proteins present
in available databases. Therefore, the functions of the putative
products encoded by these ORFs are unknown. Since these ORFs are not
conserved in the genomes of
29 or B103, it seems unlikely that the
putative products will play an essential role. We consider it possible
that they play a role in interaction with the infected host. Note that
whereas
29 and B103 are able to infect B. subtilis and
various other Bacillus species, GA-1 seems to infect only a
specific, still undefined, Bacillus species (see above).
Clearly, additional studies are required to attribute a function to
these ORFs.
EARLY OPERON LOCATED AT THE RIGHT SIDE OF THE PHAGE
GENOMES
|
|
|---|
All three phages contain an early-expressed operon located
at the right side of their genome (Fig. 2). Genes 17 and 16.7, which
are the only ones conserved in all three phage genomes, are discussed
below. In
29, this operon also contains genes 16.9 and 16.8, which, together with genes 17 and 16.7, are transcribed from promoter
C2. The
29 ORFs 16.6 and 16.5 may be transcribed from promoters C2
and C1. By Western blot analysis, the products of
29 genes 16.9 and
16.8 have been detected in infected cells (our unpublished results);
their function, however, is still unknown. B103 and GA-1 do not contain
homologues of these two genes. ORF 16.5, but not ORF 16.6, is conserved
in B103. Neither of these two ORFs is conserved in GA-1.
In B103, gene 17 and ORFs b to d may be transcribed from promoter C2
and gene 16.7 and ORF 16.5 may be transcribed from promoters C2 and
C1a. The deduced protein sequences of ORFs b to d do not show
significant homology to those of
29 or GA-1 or those of proteins
present in available databases, and their function is unknown.
Compared to those of
29 and B103, the corresponding operon
of GA-1 is considerably larger (Fig. 2). In this case, gene 17 and ORFs
B to G may be transcribed from promoter C2 and gene 16.7, ORF H, and
ORFs J to L may be transcribed from promoters C2 and C1b. The deduced
protein sequences of ORFs B to H and those of ORFs J to L do not have
significant similarity to protein sequences present in available
databases, and their function is unknown.
Gene 17
The
29 mutant sus17(112) contains a point mutation
that changes the fifth CAA codon of gene 17 into a TAA stop codon
(19). Nonsuppressor cells infected with this mutant phage
produced a reduced phage yield and viral DNA synthesis (50, 120,
153). In addition, infection with the sus17(112)
29 mutant in solid media gave only very tiny plaques
(138). Crucitti et al. (59) showed that the
presence of protein p17 is required for efficient viral DNA synthesis
when cells were infected at a low multiplicity of infection but not at
high multiplicities of infection. In addition, a moderate stimulatory
effect of p17 on in vitro
29 DNA amplification was observed when the
reaction mixtures contained small amounts of template DNA and protein
p6. Together, these results indicate that protein p17 stimulates DNA
replication under conditions of limiting amounts of template DNA and
DNA replication proteins, a situation that is expected to occur at
early infection times in cells infected at a low multiplicity.
Phages PZA and
15 are closely related to
29 (164).
Nevertheless, compared with
29, the central part of the PZA gene 17 is reorganized and portions of it have been deleted (161).
In addition, comparison of genes 17 of
29 and
15 showed that the latter contains a deletion of 63 bp near the 3' end (19).
This showed that, in particular, the central and C-terminal parts of genes 17 of
29,
15, and PZA have diverged considerably during evolution of these closely related phages. Compared to p17 of
29,
the homologues of B103 and GA-1 are 37 and 79 amino acids smaller,
respectively. The C-terminal 43 amino acids of the
29 protein p17
are absent in both the B103 and GA-1 p17 protein. Moreover, compared to
that of
29, these proteins contain additional deletions clustered in
the N-terminal and central parts of the protein. Finally, analysis of
the GA-1 p17 protein sequence revealed the presence of a putative
transmembrane-spanning domain located in the N-terminal part of the
protein (amino acids 15 to 36), suggesting that it may be an integral
membrane protein (W. J. J. Meijer, unpublished results).
Transmembrane-spanning domains are not predicted for the other p17
proteins. In fact, the p17 protein encoded by
29 is known to be a
soluble protein (59). A comparison of the gene 17 products
of
29, BS32, PZA,
15, Nf, B103, and GA-1 has been presented
previously (163).
Gene 16.7
Computer-assisted analysis of the deduced protein sequence of
29 p16.7 revealed some interesting data. First, the N-terminal region (amino acids 1 to 22) of p16.7 has a very hydrophobic character and may constitute a transmembrane-spanning domain. Membrane topology predictions indicated that p16.7 may be an integral membrane protein with its N and C regions at the outside and inside of the cell, respectively. Second, the region spanning amino acids 19 to 60 has a
high potential to form an
-helical coiled-coil structure, suggesting
that this region may function as a protein multimerization domain.
Third, the C-terminal part of the p16.7 protein sequence (amino acids
70 to 130) shows some similarity to DNA binding proteins. Thus, these
analyses suggested that p16.7 might be an integral dimeric or
multimeric DNA binding protein. Over the last decades, data have
accumulated showing that prokaryotic DNA replication, including that of
phage DNA, occurs at the cell membrane (for reviews, see references
75, 76, 130, and 192). The first evidence that
29 DNA
replication occurs at the membrane of the infected cell was obtained by
Ivarie and Pène (118). They recovered parental and
replicating
29 DNA molecules together with membranes in a rapidly
sedimenting complex in linear density gradients. Interestingly, the
formation of these complexes required an early-expressed viral
protein(s) (118). The general view is that the DNA
replication factors, probably present in an organized structure, are
recruited to one or more sites on the membrane. Despite many studies,
our current knowledge about factors involved in bacterial DNA-membrane association is rather poor. As described above, the
29 protein p1
probably plays a role in this process. The predicted features of
protein p16.7 suggested that this protein may also be involved in
membrane-associated
29 DNA replication. We showed that protein p16.7
is abundantly expressed at early times after infection
(135). In addition, p16.7 appeared to be a membrane
protein and the N-terminally located transmembrane-spanning domain was
shown to be required for its membrane localization. A derivative,
p16.7A, in which the N-terminal membrane anchor was replaced by a
histidine tag, was purified and characterized. Purified p16.7A was
shown to form dimers in solution and to have nonspecific affinity for
DNA. To study a possible role of p16.7 in in vivo phage DNA
replication, a
29 mutant containing a suppressible mutation in gene
16.7 was constructed. In vivo phage DNA replication was affected in the absence of p16.7, especially at early infection times, supporting the
view that p16.7 is involved in in vivo
29 DNA replication (135). Further insight in the role of p16.7 in in vivo
29 DNA replication was obtained by comparing the localization of
29 DNA replication in infected cells by immunofluorescence
techniques in the presence or absence of p16.7 protein
(134). In wild-type-infected cells, initiation of phage
DNA replication was localized to a single focus within the cell, nearly
always toward one end of the host cell nucleoid. Already a few minutes
later, phage replication had redistributed to multiple sites around the
periphery of the nucleoid, just under the cell membrane. These results
showed that
29 DNA replication occurs at various sites at the
membrane of the infected cell. As in wild-type-infected cells,
initiation of phage DNA replication also localized to a single focus
toward one end of the host cell nucleoid in the absence of protein
p16.7. However, in this case the redistribution of replicating phage DNA from the initial replication site to various sites surrounding the
nucleoid was strongly delayed. Thus, although p16.7 is not essential
for in vivo
29 DNA replication under laboratory conditions, it
ensures optimal phage DNA replication by spatially redistributing replicating phage DNA in infected cells.
Gene 16.7 homologues are present in the genomes of both B103 and GA-1.
Whereas the deduced p16.7 protein sequences of
29 and B103 have 68%
similarity, the GA-1 p16.7 sequence is 48% similar to those of
29
and B103. A comparison of the p16.7 protein sequences of
29, B103
and GA-1 is shown in Fig. 6. Whereas the
N-terminal 80 amino acids of the
29 and B103 p16.7 sequences,
encompassing the transmembrane-spanning and coiled-coil domain, have
high similarity, this region is far less conserved in p16.7 of GA-1.
Nevertheless, this region is predicted to share the same features.
Thus, the region spanning amino acids 5 to 27 of GA-1 p16.7 is
predicted to constitute a transmembrane-spanning domain and the region
encompassing amino acids 33 to 67 is predicted to form a coiled-coil
structure, probably involved in protein dimerisation (Meijer,
unpublished). The observation that the features of this region are
conserved despite considerable deviation at the protein level suggests
that they are especially important for the localization and structure of the protein. On the other hand, the predicted DNA binding domain of
29 and B103 proteins p16.7, located in the C-terminal half of the
protein, is rather well conserved in the p16.7 sequence of GA-1 (the 56 C-terminal amino acid residues have 60% similarity). This may further
support the view that this region constitutes the functional domain of
the p16.7 protein.
|
LATE OPERON
|
|
|---|
Gene 8.5, Encoding the Head Fiber Protein
In all three phage genomes, the late genes encoding the structural
phage proteins, proteins involved in phage morphogenesis, and proteins
required for lysis of the host are present in a single operon
located in the center of the phage genome. The levels of similarity
between the various homologous proteins are presented in Table 2. A
major difference between these operons is that GA-1 does not
contain a homologue of
29 and B103 gene 8.5, encoding the head fiber
protein. GA-1 is not the first phage of the group of
29-related
phages known to lack the gene encoding the head fiber protein. Phage
M2Y, belonging to the B103 group of
29 phages, was also reported to
lack this gene (220). In fact, apart from a small deletion
in the M2Y genome, the restriction maps of M2Y and Nf are identical,
suggesting that M2Y may have arisen from Nf by deletion of gene 8.5 (220). These observations show that head fibers are not
essential for infection or morphology of phages GA-1 and M2Y. In
agreement with that, Salas et al. (183) showed that
29
phage particles from which the head fibers were released by treatment
with 50% dimethyl sulfoxide retained their infectivity. In addition,
the plating efficiency of a set of
29 mutants that were unable to
synthesize the head fiber protein was shown to be similar to that of
wild-type
29 phage (170). Together, these results show
that the head fibers are not essential for phage morphogenesis or
infection. It has been proposed that the head fibers play a role in
stabilizing the capsid (201).
Structural Phage Proteins and
29 Phage Morphogenesis
Prohead formation.
Although phage morphogenesis and
DNA packaging have not yet been analyzed for B103 or GA-1, they have
been studied extensively for
29 (for a review, see reference
9), and a highly efficient in vitro
29 DNA-packaging
system has been established (23, 96). Moreover, the
three-dimensional structures of the
29 virion and its empty prohead
precursor, obtained by reconstruction of cryoelectron microscopy
(cryo-EM) images, have been determined recently (201).
Mutant infections or in vitro assembly have been used to study the
morphogenesis pathway of
29. The prolate icosohedral proheads of
29 consist of 235 copies of the major capsid protein (p8),
approximately 180 copies of the scaffolding protein (p7), 55 dimers of
the head fiber protein (p8.5), 12 copies of the head-tail connector
(p10), 5 or 6 copies of the 174-base pRNA, and 5 or 6 copies of the
ATPase protein (p16). The major capsid proteins are organized as
hexameric structures at each of the threefold axes and as pentameric
structures at each of the fivefold axes. The head fibers attach as
dimers to the p8 subunits at quasi-threefold axes that relate one
pentamer to a pair of hexamers. The pentameric opening in the prohead,
occupied by the structure of the 12 connector molecules, is too small
to accommodate insertion of this rigid connector structure after
prohead shell assembly. Therefore, it is believed that the connector
structure is the origin from which shell assembly is initiated
(95). The observation that isometric particles are formed
in gene 7 mutant-infected cells suggests an interaction between p7 and
connector protein (9). The structure formed by the
head-tail connector protein and the pRNA molecules forms an extremely
efficient DNA-translocating motor that, together with the aid of the
DNA packaging protein p16 and ATP, actively pumps the
29 DNA into
the prohead (for reviews, see references 53, 108, and
213).
DNA translocating/packaging machine.
(i) Connector.
The head-tail connector is a preformed oligomer with 12-fold
symmetry (49; for reviews, see references 53 and
213). Its structure has been studied by atomic force microscopy
(154), cryo-EM of two-dimensional arrays
(212), immunoelectron microscopy (211), and
X-ray crystallography (11, 92, 193). In addition, the
topology of the connector and other components of the packaging machinery has been studied (112). The 12 connector
molecules assemble into a toroidal structure with a total height of 75 Å. A channel runs along the longitudinal axis, which also has
a tronco-conical or bottle-neck shape (diameter of about 36 Å
at the narrow end, increasing to 60 Å at the wide end). The
connector structure can be divided into three main regions: the narrow
end, the central part, and the wide end. Whereas the wide end has a
12-fold symmetry, the narrow end has an apparent 6-fold symmetry. The
connector is positioned such that only the narrow end protrudes from
the portal vertex of the prohead; the wide end of the connector is buried inside the prohead (112, 201, 212). The structure
of the connector resembles a propeller. It uses a fitting mechanism that maintains the connector at its place in the prohead vertex but
allows rotation with respect to the prohead. As discussed below,
encapsidation of
29 DNA probably involves rotation of the connector
structure. It is worth noting that the
29 connector has a number of
important similarities to other toroidal translocases such as several
helicases, processivity factors, and exonucleases, suggesting that the
mechanism of DNA movement coupled to ATP hydrolysis used by these
various multiprotein complexes may be based on similar principles
(reviewed in reference 53).
(ii) pRNA ring.
Surprisingly, it was shown that in
vivo and in vitro packaging of
29 DNA required a specific RNA
molecule that is encoded by
29 (93, 94, 97, 205). This
RNA molecule, named pRNA, is required for both the translocation and
the selection of the
29 DNA to be packaged (5, 214).
The
29 pRNA is a small molecule of 174 nucleotides, although a
C-terminally truncated form of 120 nucleotides has the full activity of
the 174-nucleotide form. In contrast to all the other components of the
prohead and mature phage particle, the pRNA is not encoded by the late
operon but is constitutively expressed from the A1 promoter
(see above), which is located in the left part of the genome (Fig. 2).
The pRNA, as the connector, has received considerable attention, and major advances in determination of its structure and function have been
made during the last few years. Mg2+ induces a
conformational change in the pRNA, which leads to its binding to the
connector (55). The secondary pRNA structure has a high
helical content, containing seven bulges and three loops (12, 57,
204). Recently, it has been shown that intermolecular pairing
between bases of two loops, bases 45 to 48 (AACC) and bases 85 to 82 (UUGG), leads to a ring-like structure with a hole in the middle
(99, 229). Using functional analyses, evidence has been
provided that the active form of the pRNA ring is composed of 6 pRNA
molecules (99, 229). Nevertheless, cryo-EM and image reconstruction analyses of
29 proheads indicate a pentameric pRNA
ring (193).
29 DNA and probably is responsible for the
specificity of the packaging of
29 DNA from its left end
(22). The view that the cyclic pRNA structure interacts with the accessible end of the connector, made up of amino acids 1 to
94, is experimentally supported by analysis of site-directed mutants
with mutations in this region of the connector, protein p10
(66). The RNA binding domain of p10 would include amino acids 21 to 94. In addition, the positively charged N terminus of p10
was shown to be absolutely required for DNA packaging as well as for
efficient DNA binding (67).
In addition to that of
29, the sequence and predicted
secondary structure of the GA-1-encoded pRNA have been described
(12). An updated version that also includes the sequence
and predicted secondary structure of the B103-encoded pRNA has been
recently published (57). Despite a very low level of
sequence identity among these pRNAs, their predicted secondary
structures show a high level of similarity (12, 57). In
addition, similar secondary structures were predicted for pRNAs of
other
29-related phages such as PZA (belonging to group I
29
phages) and M2 and Nf (belonging to group II
29 phages). In all of
these pRNAs, the loops involved in intermolecular pRNA interactions, as
demonstrated for the
29 pRNA (see above), contain complementary
sequences. The bases involved are 5'-AACC/UUGG-5' for
29, 5'-UAUC/AUAG-5' for B103, and 5'-CC/GG-5' for GA-1. The requirement of at least one GC pair was
demonstrated for
29 pRNA (57). The observation that the
paired sequences of the two loops of all pRNAs analyzed contain at
least one GC pair is therefore, in agreement with the experimental
data. In addition, Zhang et al. (229) demonstrated that
base pairing of
29 residues (5'-CC/GG-5') was sufficient
for biological activity. This conclusion may be further supported by
the finding that this is the only paired loop sequence present in GA-1 pRNA.
(iii) ATPase protein p16.
Several observations
suggest that
29 protein p16 binds to the pRNA. First, protein p16,
as well as the connector protein p10, contains an RNA recognition motif
characteristic of a number of RNA-associated proteins
(89). Second, binding of p16 to the prohead protects the
pRNA from RNase (89). Finally, cryo-EM images of partially
DNA filled proheads, but not empty proheads, revealed additional
density associated with each of the pRNA molecules. This additional
density was attributed to protein p16 (193). Protein p16
of
29 was shown to possess a DNA- and prohead-dependent ATPase
activity (97). After binding of p16 to the prohead, it binds to
29 DNA, which generates a conformational change in p16 that
allows the binding of ATP and its hydrolysis during DNA packaging (98). Later it was shown that
29 p16 activity depends
on pRNA (89). Two typical ATP binding sites were detected
in the
29 p16 sequence (98). A Walker A motif and a
Walker B motif are located in the N-terminal (amino acids 24 to 39) and
C-terminal (amino acids 248 to 256) part of the
29 p16 protein,
respectively (98). Both motifs are conserved in the p16
proteins encoded by B103 and GA-1 (our unpublished data), strongly
suggesting that these conserved motifs are required for ATP hydrolysis,
which generate the energy for DNA encapsidation. Five or six copies of
29 protein p16 are required for
29 DNA packaging (89,
193). Thus, the very efficient
29 packaging motor involves a
structure that is built from 12 connector molecules, 5 or 6 pRNA
molecules, and probably 5 or 6 p16 molecules. Probably, this situation
is similar for B103 and GA-1.
Putative mechanism of
29 DNA packaging.
Several
models for phage DNA packaging in general and
29 DNA packaging in
particular have been proposed. These have been recently reviewed by
Hendrix (108). Packaging of
29 DNA is a very
energy-consuming process since it takes approximately 1 ATP molecule to
package 2 bp of
29 DNA (98). In an attractive model, whose first version was proposed more than two decades ago
(107), it is envisioned that the ATP consumption is used
to drive rotation of the connector protein with respect to the rest of
the prohead. In particular, the mismatch between the 5-fold symmetry of
the prohead and the 12-fold symmetry of the wide end of the connector was rationalized to be crucial, because it would allow rotation of the
connector structure by reducing the energy barrier. In addition, the
exterior of the connector has no significant regions of charge
accumulation, implying an oily, smooth external surface, which would
further facilitate its rotation (193). The observation that pRNA causes a fourfold increase in the ATPase activity of protein p16 (89) suggests that the pRNA structure may play
a role in the energetics of the DNA translocation. Chen and Guo (56) showed that the six pRNA molecules act sequentially,
which favors the rotation hypothesis. These authors envision that the sequential action of the six pRNAs would result in turning of the
connector. In this case, the inter-pRNA interactions may serve as a
link to pass a signal to adjacent pRNAs. Further support for this is
the observation that the pRNAs most probably remain associated with the
prohead during the entire packaging process and thus are not needed
only for the initiation of DNA packaging (56). In a
slightly different version, it is suggested that the prohead, the pRNA
ring, and the protein p16 ATPase together act as a stator
delivering the energy for rotation of the connector (193).
In this latter model, each monomer of the pRNA ring would interact with
the head and the orientation of the pRNA would be determined by its
interaction with the head rather than with the connector.
29 DNA after binding to it
(90) and predictions of the energy consumption may support
this "wrapping" model (56). In the second model, it is
assumed that the DNA is translocated through the axial hole of the
connector protein (107). Recently, results have been
obtained that strongly favor this latter model (193).
Phage maturation.
During
29 DNA packaging, the
prohead becomes more angular and rigid (22), the surface
charge decreases, and the scaffolding p7 protein molecules are expelled
(201). After packaging, the ATPase protein p16 and the
pRNA molecules are also released from the prohead (94) by
an unknown mechanism. Next, 6 copies of the lower collar (p11), 3 or 4 copies of the tail knob (p9), and 12 appendages (dimers of protein p12*
cleaved from p12 precursor molecules) are assembled sequentially onto a
stable, DNA-filled head (45, 79, 120, 168; for a review,
see reference 9) (Fig. 1). EM analysis of purified neck
crystals without appendages (p12*) and the tail knob (p9) protein
revealed a hexagonal array of the necks composed of the connector (p10)
and protein p11, which had a hole in the middle. The diameter of the
inner, sixfold region of the neck is about 7 nm. In addition, the
connector, also called upper collar, and the lower collar (p11) were
found to be tightly bound (52, 54). Thus, the lower collar
has, as the distal end of the connector, a sixfold symmetry, which may
explain, at least in part, the high stability of this neck complex and
also may be involved in releasing the less stable bound pRNA from its
place. In the absence of the lower collar protein (p11), the tail knob
protein (p9) is unable to assemble to the phage particle
(45). This shows that first the lower collar and then the
tail knob is assembled. Removing the tail knobs from the phage results
in release of the encapsidated DNA of the particles, indicating that it
functions directly or indirectly as a mechanical stop for DNA exit
(45).
29 phage was very small. Analysis of
the empty viral heads produced under these conditions showed that they
had characteristics typical of DNA-filled particles. This indicated
that the DNA was lost after packaging and therefore suggested that
protein p13 somehow interacts with p9 and/or p11 to generate stable
mature phage particles (105, 120, 127). Using
complementation assays, García et al. (79)
demonstrated that protein p13 is required in vivo for the production of
functional protein p9. Finally, the appendages (dimers of p12*), which
are involved in the adsorption of the phage to bacteria
(215), are assembled to complete the phage particle
(44, 105, 155, 203). Gene 12 encodes a precursor protein
with a calculated molecular mass of 92 kDa. Processing of the precursor
results in the active form of the appendage protein, whose monomers
have an apparent molecular mass of 75 to 80 kDa (7, 51,
203). The proteolytic processing does not require interaction of
the precursor protein with a maturing neck structure
(203). So far, the protease responsible for processing and
the processing site(s) have not been determined. The sites for assembly
of the appendages are most probably created by the interaction of p10
and p11 (52). Final stable assembly of the appendages is
obtained only when, in addition to the connector (p10) and the
lower-collar (p11) proteins, the tail knob (p9) is also present.
Therefore, it was assumed that p9 somehow stabilizes the assembly sites
at the connector-lower-collar connection (45).
Lysis cassette.
In the three phage genomes, genes 14 and 15 encode a holin and a peptidoglycan hydrolase, respectively. Both
of these proteins are required for efficient lysis of the infected host
to release the progeny phages. Lysis is delayed when cells are infected
with gene 14 mutant
29 phages, resulting in larger burst sizes
(50). This mutation has no effect on either DNA
replication or morphogenesis of the phage, and this mutant phage is
often used for in vivo studies, since it allows analysis of phage
features at late infection times without interference of lysis. Holins,
which are small membrane proteins, introduce pores in the cell
membrane, allowing the peptidoglycan hydrolase to exit the cytoplasm
and attack the cell wall. Thus, holins control the timing of lysis.
Reviews describing structural, functional, and evolutionary aspects of
phage-encoded holins and peptidoglycan hydrolases have been published
recently (175, 218, 225-227).
(i) Holin-encoding genes of
29, B103, and GA-1.
Steiner et al. (198) demonstrated that
29 gene 14 encodes a holin. Analysis of the deduced protein sequence
of
29 gene 14 showed that it contains two or possibly three
potential transmembrane domains (198). Based on the number
and size of potential transmembrane domains, most holins can be divided
in two classes. Whereas class I holins may have two or three
transmembrane domains, class II holins are limited to two transmembrane
domains and are smaller than the class I holins. Thus, the holin of
29 belongs to class I. Gene 14 of
29 contains two potential start
codons (position 1 and 3), each with a properly spaced potential
ribosomal binding site, which would allow synthesis of two products, of
131 and 129 amino acids. Indeed, this was shown to be the case
(202). Many other holin-encoding genes use this so-called
dual start motif. Prototypes of holins with a dual start motif are
encoded by the S genes of lambda (class I) and phage 21 (class II). In both cases and probably in all other cases with a dual
start motif, despite the nearly identical sequences, the two proteins
have opposing functions, with the longer product acting as an inhibitor of the shorter product, which is called the lysis effector (references 13 and 88 and references therein). Cooperative action of
the inhibitor and effector would result in proper scheduling of cell lysis ("lysis clock"). Major progress in understanding the
molecular mechanism underlying regulation of lysis by the dual start
motif has been reported recently for the lambda encoded holin
(88).
29, even though the
second amino acid residue of the predicted inhibitor species is an Asp
instead of a Lys. Analysis of the GA-1 p14 gene shows that it does not
contain the typical dual start motif. In fact, alignment of the
29,
B103, and GA-1 holin sequences aligns the Met start residue of the GA-1
holin to the second Met residue of the predicted lysis effector species
of
29 and B103 holins (Fig. 7). The
second Met residue in the GA-1 holin is located at position 9 (Fig. 7).
However, no potential ribosomal binding site is found at the
appropriate location upstream of this second Met codon. These
observations suggest that GA-1 would encode only the lysis effector.
|
(ii) Peptidoglycan hydrolase-encoding genes of
29, B103,
and GA-1.
Gene 15 of
29, B103, and GA-1 encodes a peptidoglycan
hydrolase that, at the end of the infection cycle, attacks the cell wall, resulting in lysis of the infected cell and release of the phage
progeny. Peptidoglycan hydrolases of tailed phages can be classified
into the following groups: muramidases, amidases, peptidases, and
transglycosylases (4). The peptidoglycan hydrolases
encoded by gene 15 of
29 and B103 have a high level of homology and
both belong to the group of muramidases (83, 163, 174).
Independently of their muralytic activity, the peptidoglycan hydrolases
of phages T4, T7, lambda, and
29 have also been named lysozyme. The
peptidoglycan hydrolase encoded by gene 15 of GA-1 shows only moderate
homology to those of
29 and B103 (Table 2). Comparison of this
protein sequence to those in available databases showed that the GA-1 peptidoglycan hydrolase is most closely related to several
Bacillus-encoded autolysins (all belonging to the group of
amidases), such as CwlC of B. subtilis, B. lichenoformis,
and Bacillus halodurans (about 55% similarity), and the
peptidoglycan hydrolase gene of phage SPP1 (data not shown). As
described by Ackermann (4), there are many lines of
evidence that phage peptidoglycan hydrolases are spread by horizontal
gene transfer, e.g., exchange of these genes with their hosts. The
strong homology of the GA-1 gene to the Bacillus autolysin
genes suggests that GA-1 has "borrowed" its amidase from its host.
CONCLUSIONS AND FUTURE PERSPECTIVES
|
|
|---|
Here we have described features of the
29-related phages
29
(group I), B103 (group II), and GA-1 (group III), the result of more
than 30 years of ongoing research. We have attempted to provide a
comprehensive overview of DNA replication, regulation of transcription,
DNA packaging, phage morphogenesis, and host cell lysis. The
fundamental studies, which were focused mainly on
29, turned out to
reveal various molecular mechanisms of general biological processes.
One example is the discovery of the interesting dual role of protein p6
in activation of DNA replication and transcriptional regulation.
The recent comparative studies of the DNA polymerase, TP,
transcriptional regulator, SSB (p5), and DBP (p6) proteins of
29, B103/Nf, and GA-1 have shown that whereas the main characteristics of
these proteins are conserved, interesting differences are also found.
In particular, the observed differences will be important tools in
further unraveling the molecular mechanisms by which these proteins act
and in understand in more detail the evolutionary adaptation of these
proteins with respect to their function for their specific phage.
Another important discovery is the involvement of the pRNA in phage DNA
packaging. In particular, the finding of a mechanistic role of a joint
action of several identical units of RNA is exciting and has widened
the activities of RNA molecules. Based on the available knowledge and
the effort displayed by various laboratories, it may be expected that
the mechanism of phage DNA packaging and the exact role of the pRNA
molecules in this process will be resolved in the near future.
The idea that DNA replication is attached to an underlying structure is
gaining a wide audience in the scientific community. During the last
few years, results have been obtained indicating that replication of
eukaryotic DNA, either chromosomal or viral, takes place at specific
sites (for reviews, see references 58, 119, and 156). In
addition to the DNA polymerases, other necessary replication factors
are localized to these sites (156). Together, these
results led to the notion that eukaryotic DNA replication takes place
in so-called replication factories, each of which contains a relative
high concentration of most, if not all, of the DNA replication factors.
The replication factories remain at relatively fixed positions, and it
is believed that the DNA is threaded through them (58).
The static position of the replication factories suggests that they are
attached to a substructure. Recently, the concept of a static
replication factory has also been demonstrated for the B. subtilis chromosome (129). For prokaryotes it is well known that the membrane is the cellular substructure to which DNA
replication is attached. However, very little is known about factors
involved in substructure attachment and organization of in vivo DNA
replication in replication factories in general. The detailed knowledge
of the in vitro mechanism of
29 DNA replication forms a sound basis
for a study of the fundamental process of in vivo DNA replication. In
fact, our recent results strongly indicate that at least proteins p16.7
and p1 are involved in this process. A further characterization of
these proteins may lead to a more detailed insight in the in vivo
organization of DNA replication in general and that of
29 DNA
replication in particular.
Finally, it will be interesting to determine the functions of the putative proteins, encoded by the ORFs that are unique for GA-1. In summary, although the studies performed on these phages have resulted in a wealth of specific and general information on fundamental biological processes, there are still exciting questions to be resolved.
ACKNOWLEDGMENTS
|
|
|---|
We are indebted to Encarna Madueño for excellent assistance in sequencing.
This investigation was supported by research grants 2R01 GM27242-21 from the National Institutes of Health, PB98-0645 from the Dirección General de Investigación Científica y Técnica, and ERBFMX CT97 0125 from the European Economic Community and an Institutional grant from Fundación Ramón Areces. W.J.J.M. and J.A.H. were supported by postdoctoral fellowships from the Spanish Ministry of Education and Culture and Fundación Raul González-Salas, respectively.
FOOTNOTES
* Corresponding author. Mailing address: Centro de Biología Molecular "Severo Ochoa," Universidad Autónoma, Canto Blanco, 28049 Madrid, Spain. Phone: (34) 91 397 8435. Fax: (34) 91 397 8490. E-mail: msalas{at}cbm.uam.es.
REFERENCES
|
|
|---|
| 1. |
Abril, A. M.,
S. Marco,
J. L. Carrascosa,
M. Salas, and J. M. Hermoso.
1999.
Oligomeric structures of the phage 29 histone-like protein p6.
J. Mol. Biol.
292:581-588[CrossRef][Medline].
|
| 2. |
Abril, A. M.,
M. Salas,
J. M. Andreu,
J. M. Hermoso, and G. Rivas.
1997.
Phage 29 protein p6 is in a monomer-dimer equilibrium that shifts to higher association states at the millimolar concentrations found in vivo.
Biochemistry
36:11901-11908[CrossRef][Medline].
|
| 3. |
Abril, A. M.,
M. Salas, and J. M. Hermoso.
2000.
Identification of residues within two regions involved in self-association of viral histone-like protein p6 from phage 29.
J. Biol. Chem.
275:26404-26410 |
| 4. | Ackermann, H.-W. 1998. Tailed bacteriophages: the order Caudovirales. Adv. Virus Res. 51:135-201[Medline]. |
| 5. |
Anderson, D. L., and J. W. Bodley.
1990.
Role of RNA in bacteriophage 29 DNA packaging.
J. Struct. Biol.
104:70-74[CrossRef][Medline].
|
| 6. |
Anderson, D. L.,
D. D. Hickman, and B. E. Reilly.
1966.
Structure of Bacillus subtilis bacteriophage 29 and the length of 29 deoxyribonucleic acid.
J. Bacteriol.
91:2081-2089 |
| 7. |
Anderson, D. L., and B. E. Reilly.
1974.
Analysis of bacteriophage 29 gene function: protein synthesis in suppressor-sensitive mutant infection of Bacillus subtilis.
J. Virol.
13:211-221 |
| 8. |
Anderson, D. L., and B. E. Reilly.
1976.
Analysis of gene function in Bacillus subtilis bacteriophage 29, p. 254-274.
In
D. Schlessinger (ed.), Microbiology 1976 American Society for Microbiology, Washington, D.C.
|
| 9. |
Anderson, D. L., and B. E. Reilly.
1993.
Morphogenesis of bacteriophage 29, p. 859-867.
In
A. L. Sonenshein, J. A. Hoch, and R. Losick (ed.), Bacillus subtilis and other gram-positive bacteria: biochemistry, physiology, and molecular genetics. American Society for Microbiology, Washington, D.C.
|
| 10. |
Arwert, F., and G. Venema.
1974.
Protease-sensitive transfection of Bacillus subtilis with bacteriophage GA-1 DNA: a probable case of heterologous transfection.
J. Virol.
13:584-589 |
| 11. |
Badasso, M. O.,
P. G. Leiman,
Y. Tao,
Y. He,
D. H. Ohlendorf,
M. G. Rossmann, and D. Anderson.
2000.
Purification, crystallization and initial X-ray analysis of the head-tail connector of bacteriophage 29.
Acta. Crystallogr. Sar. D
56:1187-1190[CrossRef].
|
| 12. |
Bailey, S.,
J. Wichitwechkarn,
D. Johnson,
B. E. Reilly,
D. L. Anderson, and J. W. Bodley.
1990.
Phylogenetic analysis and secondary structure of the Bacillus subtilis bacteriophage RNA required for DNA packaging.
J. Biol. Chem.
265:22365-22370 |
| 13. | Barenboim, M., C.-Y. Chang, F. dib Hajj, and R. Young. 1999. Characterization of the dual start motif of a class II holin gene. Mol. Microbiol. 32:715-727[CrossRef][Medline]. |
| 14. |
Barthelemy, I.,
R. P. Mellado, and M. Salas.
1989.
In vitro transcription of bacteriophage 29 DNA: inhibition of early promoters by the viral replication protein p6.
J. Virol.
63:460-462 |
| 15. | Barthelemy, I., and M. Salas. 1989. Characterization of a new prokaryotic transcriptional activator and its DNA recognition site. J. Mol. Biol. 208:225-232[CrossRef][Medline]. |
| 16. |
Barthelemy, I.,
M. Salas, and R. P. Mellado.
1986.
In vivo transcription of bacteriophage 29 DNA: transcription initiation sites.
J. Virol.
60:874-879 |
| 17. |
Barthelemy, I.,
M. Salas, and R. P. Mellado.
1987.
In vivo transcription of bacteriophage 29 DNA: transcription termination.
J. Virol.
61:1751-1755 |
| 18. | Beese, L. S., and T. A. Steitz. 1991. Structural basis for the 3'-5' exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. EMBO J. 10:25-33[Medline]. |
| 19. |
Benes, V.,
L. Arnold,
J. Smrt, and V. Paces.
1989.
Nucleotide sequence of the right early region of Bacillus phage 15 and comparison with related phages: reorganization of gene 17 during evolution.
Gene
75:341-347[CrossRef][Medline]
|
| 20. | Bernad, A., L. Blanco, J. M. Lázaro, G. Martín, and M. Salas. 1989. A conserved 3'-5' exonuclease active site in prokaryotic and eukaryotic DNA polymerases. Cell 59:219-228[CrossRef][Medline]. |
| 21. |
Bernad, A.,
J. M. Lázaro,
M. Salas, and L. Blanco.
1990.
The highly conserved amino acid sequence Tyr-Gly-Asp-Thr-Asp-Ser in -like DNA polymerases is required by phage 29 DNA polymerase for protein-primed initiation and polymerization.
Proc. Natl. Acad. Sci. USA
87:4610-4614 |
| 22. |
Bjornsti, M. A.,
B. E. Reilly, and D. Anderson.
1983.
Morphogenesis of bacteriophage 29 of Bacillus subtilis: oriented and quantized in vitro packaging of DNA protein gp3.
J. Virol.
45:383-396 |
| 23. |
Bjornsti, M. A.,
B. E. Reilly, and D. L. Anderson.
1981.
In vitro assembly of the Bacillus subtilis bacteriophage 29.
Proc. Natl. Acad. Sci. USA
78:5861-5865 |
| 24. |
Blanco, L.,
A. Bernad,
J. A. Esteban, and M. Salas.
1992.
DNA-independent deoxynucleotidylation of the 29 terminal protein by the 29 DNA polymerase.
J. Biol. Chem.
267:1225-1230 |
| 25. |
Blanco, L.,
A. Bernad,
J. M. Lázaro,
G. Martín,
C. Garmendia, and M. Salas.
1989.
Highly efficient DNA synthesis by the phage 29 DNA polymerase. Symmetrical mode of DNA replication.
J. Biol. Chem.
264:8935-8940 |
| 26. |
Blanco, L.,
J. Gutiérrez,
J. M. Lázaro,
A. Bernad, and M. Salas.
1986.
Replication of phage 29 DNA in vitro: role of the viral protein p6 in initiation and elongation.
Nucleic Acids Res.
14:4923-4937 |
| 27. |
Blanco, L.,
J. M. Lázaro,
M. De Vega,
A. Bonnin, and M. Salas.
1994.
Terminal protein-primed DNA amplification.
Proc. Natl. Acad. Sci. USA
91:12198-12202 |
| 28. |
Blanco, L.,
I. Prieto,
J. Gutiérrez,
A. Bernad,
J. M. Lázaro,
J. M. Hermoso, and M. Salas.
1987.
Effect of NH4+ ions on 29 DNA-protein p3 replication: formation of a complex between the terminal protein and the DNA polymerase.
J. Virol.
61:3983-3991 |
| 29. |
Blanco, L., and M. Salas.
1984.
Characterization and purification of a phage 29-encoded DNA polymerase required for the initiation of replication.
Proc. Natl. Acad. Sci. USA
81:5325-5329 |
| 30. |
Blanco, L., and M. Salas.
1985.
Replication of phage 29 DNA with purified terminal protein and DNA polymerase: synthesis of full length DNA.
Proc. Natl. Acad. Sci. USA
82:6404-6408 |
| 31. |
Blanco, L., and M. Salas.
1995.
Bacteriophage 29 DNA polymerase, p. 328-341.
In
F. Eckstein, and D. M. J. Lilley (ed.), Nucleic acids and molecular biology. Springer-Verlag KG, Berlin, Germany.
|
| 32. |
Blanco, L., and M. Salas.
1996.
Relating structure to function in 29 DNA polymerase.
J. Biol. Chem.
271:8509-8512 |
| 33. |
Blasco, M. A.,
L. Blanco,
E. Parés,
M. Salas, and A. Bernad.
1990.
Structural and functional analysis of temperature-sensitive mutants of the phage 29 DNA polymerase.
Nucleic Acids Res.
18:4763-4770[CrossRef][Medline].
|
| 34. |
Blasco, M. A.,
J. M. Lázaro,
A. Bernad,
L. Blanco, and M. Salas.
1992.
29 DNA polymerase active site: mutants in conserved residues Tyr254 and Tyr390 are affected in dNTP binding.
J. Biol. Chem.
267:19427-19434 |
| 35. |
Blasco, M. A.,
J. M. Lázaro,
L. Blanco, and M. Salas.
1993a.
29 DNA polymerase active site. Residue Asp249 of conserved amino acid motif DX2SLYP is critical for synthetic activities.
J. Biol. Chem.
268:24106-24113 |
| 36. |
Blasco, M. A.,
J. M. Lázaro,
L. Blanco, and M. Salas.
1993b.
29 DNA polymerase active site. The conserved amino acid motif "Kx3NSxYG" is involved in template-primer binding and dNTP selection.
J. Biol. Chem.
268:16763-16770 |
| 37. |
Blasco, M. A.,
J. Méndez,
J. M. Lázaro,
L. Blanco, and M. Salas.
1995.
Primer-terminus stabilization at the 29 DNA polymerase active site: mutational analysis of conserved motif KxY.
J. Biol. Chem.
270:2735-2740 |
| 38. |
Bonnin, A.,
J. M. Lázaro,
L. Blanco, and M. Salas.
1999.
A single tyrosine prevents insertion of ribonucleotides in the eukaryotic-type 29 DNA polymerase.
J. Mol. Biol.
290:241-251[CrossRef][Medline].
|
| 39. | Bradley, D. E. 1965. The isolation and morphology of some new bacteriophages specific for Bacillus and Acetobacter species. J. Gen. Microbiol. 41:233-241[Medline]. |
| 40. |
Bravo, A.,
B. Illana, and M. Salas.
2000.
Compartmentalization of phage 29 DNA replication: interaction between the primer terminal protein and the membrane-associated protein p1.
EMBO J.
19:5575-5584[CrossRef][Medline].
|
| 41. |
Bravo, A., and M. Salas.
1997.
Initiation of bacteriophage 29 DNA replication in vivo: assembly of a membrane-associated multiprotein complex.
J. Mol. Biol.
269:102-112[CrossRef][Medline].
|
| 42. |
Bravo, A., and M. Salas.
1998.
Polymerization of bacteriophage 29 replication protein p1 into protofilament sheets.
EMBO J.
17:6096-6105[CrossRef][Medline].
|
| 43. |
Caldentey, J.,
L. Blanco,
D. H. Bamford, and M. Salas.
1993.
In vitro replication of bacteriophage PRD1 DNA. Characterization of the protein-primed initiation site.
Nucleic Acids Res.
21:3725-3730 |
| 44. |
Camacho, A.,
F. Jiménez,
J. de la Torre,
J. L. Carrascosa,
R. P. Mellado,
C. Vásquez,
E. Viñuela, and M. Salas.
1977.
Assembly of Bacillus subtilis phage 29. I. Mutants in the cistrons coding for the structural proteins.
Eur. J. Biochem.
73:39-55[Abstract].
|
| 45. |
Camacho, A.,
F. Jiménez,
E. Viñuela, and M. Salas.
1979.
Order of assembly of the lower collar and the tail proteins of Bacillus subtilis bacteriophage 29.
J. Virol.
29:540-545 |
| 46. |
Camacho, A., and M. Salas.
1999.
Effect of mutations in the "extended 10" motif of three Bacillus subtilis A-RNA polymerase-dependent promoters.
J. Mol. Biol.
286:683-693[CrossRef][Medline].
|
| 47. |
Camacho, A., and M. Salas.
2000.
Pleiotropic effect of protein p6 on the viral cycle of bacteriophage 29.
J. Bacteriol.
182:6927-6932 |
| 48. |
Canceill, D.,
E. Vigueras, and S. D. Ehrlich.
1999.
Replication slippage of different DNA polymerases is inversely related to their strand displacement efficiency.
J. Biol. Chem.
274:27481-27490 |
| 49. |
Carazo, J. M.,
L. E. Donate,
L. Herranz,
J. P. Secilla, and J. L. Carrascosa.
1986.
Three-dimensional reconstruction of the connector of bacteriophage 29 at 1.8 nm resolution.
J. Mol. Biol.
192:853-867[CrossRef][Medline].
|
| 50. |
Carrascosa, J. L.,
A. Camacho,
F. Moreno,
F. Jiménez,
R. P. Mellado,
E. Viñuela, and M. Salas.
1976.
Bacillus subtilis phage 29; characterization of gene products and functions.
Eur. J. Biochem.
66:229-241[Abstract].
|
| 51. |
Carrascosa, J. L.,
A. Camacho,
E. Viñuela, and M. Salas.
1974.
A precursor of the neck appendage protein of B. subtilis phage 29.
FEBS Lett.
44:317-321[CrossRef][Medline].
|
| 52. |
Carrascosa, J. L.,
J. M. Carazo, and N. García.
1983.
Structural localization of the proteins of the head to tail connecting region of bacteriophage 29.
Virology
124:133-144[CrossRef][Medline].
|
| 53. | Carrascosa, J. L., and J. M. Valpuesta. 1999. Bacteriophage connectors: structural features of a DNA translocating motor. Recent Res. Dev. Virol. 1:449-465. |
| 54. |
Carrascosa, J. L.,
E. Viñuela,
N. García, and A. Santisteban.
1982.
Structure of the head-tail connector of bacteriophage 29.
J. Mol. Biol.
154:311-324[CrossRef][Medline].
|
| 55. |
Chen, C., and P. Guo.
1997.
Mg2+-induced conformational change of packaging RNA for procapsid recognition and binding during phage 29 DNA encapsidation.
J. Virol.
71:495-500[Abstract].
|
| 56. |
Chen, C., and P. Guo.
1997.
Sequential action of six virus-encoded DNA-packaging RNAs during phage 29 genomic DNA translocation.
J. Virol.
71:3864-3871[Abstract].
|
| 57. |
Chen, C.,
C. Zhang, and P. Guo.
1999.
Sequence requirements for hand-in hand interaction in formation of RNA dimers and hexamers to gear 29 DNA translocation motor.
RNA
5:805-818[Abstract].
|
| 58. |
Cook, P. R.
1999.
The organization of replication and transcription.
Science
284:1790-1795 |
| 59. |
Crucitti, P.,
J. M. Lázaro,
V. Benes, and M. Salas.
1998.
Bacteriophage 29 early protein p17 is conditionally required for the first rounds of viral DNA replication.
Gene
223:135-142[CrossRef][Medline].
|
| 60. |
Derbyshire, V.,
J. K. Pinsonneault, and C. M. Joyce.
1995.
Structure-function analysis of 3' 5'-exonuclease of DNA polymerases.
Methods Enzymol.
262:363-385[Medline].
|
| 61. |
De Vega, M.,
L. Blanco, and M. Salas.
1998.
29 DNA polymerase residue Ser122, a single-stranded DNA ligand for 3'-5' exonucleolysis, is required to interact with the terminal protein.
J. Biol. Chem.
273:28966-28977 |
| 62. |
De Vega, M.,
L. Blanco, and M. Salas.
1999.
Processive proofreading and the spatial relationship between polymerase and exonuclease active sites of bacteriophage 29 DNA polymerase.
J. Mol. Biol.
292:39-51[CrossRef][Medline].
|
| 63. | De Vega, M., T. Ilyina, J. M. Lázaro, M. Salas, and L. Blanco. 1997. An invariant lysine residue is involved in catalysis at the 3'-5' exonuclease active site of eukaryotic-type DNA polymerases. J. Mol. Biol. 270:65-78[CrossRef][Medline]. |
| 64. |
De Vega, M.,
J. M. Lázaro,
M. Salas, and L. Blanco.
1996.
Primer-terminus stabilization at the 3'-5' exonuclease active site of 29 DNA polymerase. Involvement of two amino acid residues highly conserved in proofreading DNA polymerases.
EMBO J,
15:1182-1192[Medline].
|
| 65. |
De Vega, M.,
J. M. Lázaro,
M. Salas, and L. Blanco.
1998.
Mutational analysis of 29 DNA polymerase residues acting as ssDNA ligands for 3'-5' exonucleolysis.
J. Mol. Biol.
279:807-822[CrossRef][Medline].
|
| 66. |
Donate, L. E.,
J. M. Valpuesta,
C. Mier,
F. Rojo, and J. L. Carrascosa.
1993.
Characterization of an RNA-binding domain in the bacteriophage 29 connector.
J. Biol. Chem.
268:20198-20204 |
| 67. |
Donate, L. E.,
J. M. Valpuesta,
A. Rocher,
E. Mendez,
F. Rojo,
M. Salas, and J. L. Carrascosa.
1992.
Role of the amino-terminal domain of bacteriophage 29 connector in DNA binding and packaging.
J. Biol. Chem.
267:10919-10924 |
| 68. | Dufour, E., J. Méndez, J. M. Lázaro, M. De Vega, L. Blanco, and M. Salas. 2000. An aspartic acid residue in TPR-1, a specific region of protein-priming DNA polymerases, is required for the functional interaction with primer terminal protein. J. Mol. Biol. 304:289-300[CrossRef][Medline]. |
| 69. |
Elías-Arnanz, M., and M. Salas.
1999.
Functional interactions between a phage histone-like protein and a transcriptional factor in regulation of 29 early-late transcriptional switch.
Genes Dev.
13:2502-2513 |
| 70. |
Escarmís, C.,
D. Guirao, and M. Salas.
1989.
Replication of recombinant 29 DNA molecules in Bacillus subtilis protoplasts.
Virology
169:152-160[CrossRef][Medline].
|
| 71. |
Esteban, J. A.,
L. Blanco,
L. Villar, and M. Salas.
1997.
In vitro evolution of terminal protein-containing genomes.
Proc. Natl. Acad. Sci. USA
94:2921-2926 |
| 72. |
Esteban, J. A.,
M. Salas, and L. Blanco.
1993.
Fidelity of 29 DNA polymerase. Comparison between protein-primed initiation and DNA polymerization.
J. Biol. Chem.
268:2719-2726 |
| 73. |
Esteban, J. A.,
M. S. Soengas,
M. Salas, and L. Blanco.
1994.
3' 5' exonuclease active site of 29 DNA polymerase. Evidence favoring a metal ion-assisted reaction mechanism.
J. Biol. Chem.
269:31946-31954 |
| 74. | Fauquet, C. M. 1999. Taxonomy, classification and nomenclature of viruses, p. 1730-1756. In A. Granoff, and R. G. Webster (ed.), Encyclopaedia of virology, 2nd ed. Academic Press, Ltd, London, United Kingdom. |
| 75. | Firshein, W. 1989. Role of the DNA/membrane complex in prokaryotic DNA replication. Annu. Rev. Microbiol. 43:89-120[CrossRef][Medline]. |
| 76. | Firshein, W., and P. Kim. 1997. Plasmid replication and partition in Escherichia coli: is the cell membrane the key? Mol. Microbiol. 23:1-10[CrossRef][Medline]. |
| 77. | Freire, R., M. Salas, and J. M. Hermoso. 1994. A new protein domain for binding to DNA through the minor groove. EMBO J. 13:4353-4360[Medline]. |
| 78. |
Freire, R.,
M. Serrano,
M. Salas, and J. M. Hermoso.
1996.
Activation of replication origins in 29-related phages requires the recognition of initiation proteins to specific nucleoprotein complexes.
J. Biol. Chem.
271:31000-31007 |
| 79. |
García, J. A.,
J. L. Carrascosa, and M. Salas.
1983.
Assembly of the tail protein of the Bacillus subtilis phage 29.
Virology
125:18-30[CrossRef][Medline].
|
| 80. |
García, J. A.,
M. A. Peñalva,
L. Blanco, and M. Salas.
1984.
Template requirements for initiation of phage 29 DNA replication in vitro.
Proc. Natl. Acad. Sci. USA
81:80-84 |
| 81. |
Garmendia, C.,
A. Bernad,
J. A. Esteban,
L. Blanco, and M. Salas.
1992.
The bacteriophage 29 DNA polymerase, a proofreading enzyme.
J. Biol. Chem.
267:2594-2599 |
| 82. |
Garmendia, C.,
M. Salas, and J. M. Hermoso.
1988.
Site-directed mutagenesis in the DNA linking site of bacteriophage 29 terminal protein: isolation and characterization of a Ser232Thr mutant.
Nucleic Acids Res.
16:5727-5740 |
| 83. |
Garvey, K. J.,
M. S. Saedi, and J. Ito.
1986.
Nucleotide sequence of Bacillus phage 29 genes 14 and 15: homology of gene 15 with other phage lysozymes.
Nucleic Acids Res.
14:10001-10008 |
| 84. |
Garvey, K. J.,
H. Yoshikawa, and J. Ito.
1985.
The complete sequence of the Bacillus phage 29 right early region.
Gene
40:301-309[CrossRef][Medline].
|
| 85. |
Gascón, I.,
C. Gutiérrez, and M. Salas.
2000.
Structural and functional comparative study of the complexes formed by viral 29, Nf and GA-1 SSB proteins with DNA.
J. Mol. Biol.
296:989-999[CrossRef][Medline].
|
| 86. |
Gascón, I.,
J. M. Lázaro, and M. Salas.
2000.
Differential functional behavior of viral 29, Nf, and GA-1 SSB proteins.
Nucleic Acids Res.
28:2034-2042 |
| 87. |
González-Huici, V.,
J. M. Lázaro,
M. Salas, and J. M. Hermoso.
2000.
Specific recognition of parental terminal protein by DNA polymerase for initiation of protein-primed DNA replication.
J. Biol. Chem.
275:14678-14683 |
| 88. |
Graschopf, A., and U. Bläsi.
1999.
Molecular function of the dual-start motif in the S holin.
Mol. Microbiol.
33:569-582[CrossRef][Medline].
|
| 89. |
Grimes, S., and D. Anderson.
1990.
RNA dependence of the bacteriophage 29 DNA packaging ATPase.
J. Mol. Biol.
215:559-566[CrossRef][Medline].
|
| 90. |
Grimes, S., and D. Anderson.
1997.
The bacteriophage 29 packaging proteins supercoil the DNA ends.
J. Mol. Biol.
266:901-914[CrossRef][Medline].
|
| 91. | Grunow, R., M. Schonherr, U. Taubeneck, and I. Zimmermann. 1981. Zur Struktur von Bakteriophagen aus Enzym-produzierenden Bacillus Kulturen. Acta Biotechnol. 1:17-19[CrossRef]. |
| 92. |
Guasch, A.,
J. Pous,
A. Párraga,
J. M. Valpuesta,
J. L. Carrascosa, and M. Coll.
1998.
Crystallographic analysis reveals the 12-fold symmetry of the bacteriophage 29 connector particles.
J. Mol. Biol.
281:219-225[CrossRef][Medline].
|
| 93. |
Guo, P.,
S. Bailey,
J. W. Bodley, and D. Anderson.
1987.
Characterization of the small RNA of the bacteriophage 29 DNA packaging machine.
Nucleic Acids Res.
15:7081-7090 |
| 94. |
Guo, P.,
S. Erickson, and D. Anderson.
1987.
A small viral RNA is required for in vitro packaging of bacteriophage 29 DNA.
Science
236:690-694 |
| 95. |
Guo, P.,
S. Erickson,
W. Xu,
N. Olson,
T. S. Baker, and D. Anderson.
1991.
Regulation of the phage 29 prohead shape and size by the portal vertex.
Virology
183:366-373[CrossRef][Medline].
|
| 96. |
Guo, P.,
S. Grimes, and D. Anderson.
1986.
A defined system for in vitro packaging of DNA-gp3 of the Bacillus subtilis bacteriophage 29.
Proc. Natl. Acad. Sci. USA
83:3505-3509 |
| 97. |
Guo, P.,
C. Peterson, and D. Anderson.
1987.
Initiation events in in vitro packaging of bacteriophage 29 DNA-p3.
J. Mol. Biol.
197:219-228[CrossRef][Medline].
|
| 98. |
Guo, P.,
C. Peterson, and D. Anderson.
1987.
Prohead and DNA-gp3-dependent ATPase activity of the DNA packaging protein gp16 of bacteriophage 29.
J. Mol. Biol.
197:229-236[CrossRef][Medline].
|
| 99. |
Guo, P.,
C. Zhang,
C. Chen,
K. Garver, and M. Trottier.
1998.
Inter-RNA interaction of phage 29 pRNA to form a hexameric complex for viral DNA transportation.
Mol. Cell
2:149-155[CrossRef][Medline].
|
| 100. |
Gutiérrez, C.,
R. Freire,
M. Salas, and J. M. Hermoso.
1994.
Assembly of phage 29 genome with viral protein p6 into a compact complex.
EMBO J.
13:269-276[Medline].
|
| 101. |
Gutiérrez, C.,
G. Martín,
J. M. Sogo, and M. Salas.
1991.
Mechanism of stimulation of DNA replication by bacteriophage 29 single-stranded DNA-binding protein p5.
J. Biol. Chem.
266:2104-2111 |
| 102. |
Gutiérrez, C.,
J. M. Sogo, and M. Salas.
1991.
Analysis of replicative intermediates produced during bacteriophage 29 DNA replication in vitro.
J. Mol. Biol.
222:983-994[CrossRef][Medline].
|
| 103. |
Gutiérrez, J.,
J. A. García,
L. Blanco, and M. Salas.
1986.
Cloning and template activity of the origins of replication of phage 29 DNA.
Gene
43:1-11[CrossRef][Medline].
|
| 104. |
Gutiérrez, J.,
J. Vinós,
I. Prieto,
E. Méndez,
J. M. Hermoso, and M. Salas.
1986.
Signals in the 29 DNA-terminal protein template for the initiation of phage 29 DNA replication.
Virology
155:474-483[CrossRef][Medline].
|
| 105. |
Hagen, E. W.,
B. E. Reilly,
M. E. Tosi, and D. L. Anderson.
1976.
Analysis of gene function of bacteriophage 29 of Bacillus subtilis: identification of cistrons essential for viral assembly.
J. Virol.
19:501-517 |
| 106. |
Helmann, J. D.
1995.
Compilation and analysis of Bacillus subtilis A-dependent promoter sequences: evidence for extended contact between RNA polymerase and upstream promoter DNA.
Nucleic Acids Res.
23:2351-2360 |
| 107. |
Hendrix, R. W.
1978.
Symmetry mismatch and DNA packaging in large bacteriophages.
Proc. Natl. Acad. Sci. USA
75:4779-4783 |
| 108. | Hendrix, R. W. 1998. Bacteriophage DNA packaging: RNA gears in a DNA transport machine. Cell 94:147-150[CrossRef][Medline]. |
| 109. |
Hermoso, J. M.,
E. Méndez,
F. Soriano, and M. Salas.
1985.
Location of the serine residue involved in the linkage between the terminal protein and the DNA of 29.
Nucleic Acids Res.
13:7715-7728 |
| 110. |
Holder, R. D., and H. R. Whiteley.
1983.
In vitro synthesis of late bacteriophage 29 RNA.
J. Virol.
46:690-702 |
| 111. | Horcajadas, J. A., M. Monsalve, F. Rojo, and M. Salas. 1999. The switch from early to late transcription in phage GA-1: characterization of the regulatory protein p4G. J. Mol. Biol. 290:917-928[CrossRef][Medline]. |
| 112. |
Ibarra, B.,
J. L. Carrascosa,
O. Llorca,
M. Valle, and J. M. Valpuesta.
2000.
Topology of the components of the DNA packaging machinery in the phage 29 prohead.
J. Mol. Biol.
298:807-815[CrossRef][Medline].
|
| 113. | Ikeda, Y., H. Saito, K. Miura, J. Takagi, and H. Aoki. 1965. DNA base composition, susceptibility to bacteriophages, and interspecific transformation as criteria for classification in the genus Bacillus. J. Gen. Appl. Microbiol. 11:181-190. |
| 114. | Illana, B., L. Blanco, and M. Salas. 1996. Functional characterization of the genes coding for the terminal protein and DNA polymerase from bacteriophage GA-1. Evidence for a sliding-back mechanism during protein-primed GA-1 DNA replication. J. Mol. Biol. 264:453-464[CrossRef][Medline]. |
| 115. |
Illana, B.,
J. M. Lázaro,
C. Gutiérrez,
W. J. J. Meijer,
L. Blanco, and M. Salas.
1999.
Phage 29 terminal protein residues Asn80 and Tyr82 are recognition elements of the replication origins.
J. Biol. Chem.
274:15073-15079 |
| 116. |
Illana, B.,
A. Zaballos,
L. Blanco, and M. Salas.
1998.
The RGD sequence in phage 29 terminal protein is required for interaction with 29 DNA polymerase.
Virology
248:12-19[CrossRef][Medline].
|
| 117. |
Inciarte, M. R.,
M. Salas, and J. M. Sogo.
1980.
The structure of replicating DNA molecules of Bacillus subtilis phage 29.
J. Virol.
34:187-190 |
| 118. |
Ivarie, R. D., and J. J. Pène.
1973.
DNA replication in bacteriophage 29: the requirement of a viral-specific product for association of 29 DNA with the cell membrane of Bacillus amyloliquefaciens.
Virology
52:351-362[CrossRef][Medline].
|
| 119. | Jackson, D. A., and C. S. Cooper. 1995. The structural basis of nuclear function. Int. Rev. Cytol. 162:125-149. |
| 120. |
Jiménez, F.,
A. Camacho,
J. de la Torre,
E. Viñuela, and M. Salas.
1977.
Assembly of Bacillus subtilis phage 29. 2. Mutants in the cistrons coding for the non-structural proteins.
Eur. J. Biochem.
73:57-72[Abstract].
|
| 121. | Joyce, C. M., and T. A. Steitz. 1994. Function and structure relationships in DNA polymerases. Annu. Rev. Biochem. 63:777-822[CrossRef][Medline]. |
| 122. |
Kawamura, F., and J. Ito.
1977.
Transcription of the genome of bacteriophage 29: isolation and mapping of the major early mRNA synthesized in vivo and in vitro.
J. Virol.
23:562-577 |
| 123. |
Keilty, S., and M. Rosenberg.
1987.
Constitutive function of a positively regulated promoter reveals new sequences essential for activity.
J. Biol. Chem.
262:6389-6395 |
| 124. |
King, A. J.,
W. R. Teertstra, and P. C. van der Vliet.
1997.
Dissociation of the protein primer and DNA polymerase after initiation of adenovirus DNA replication.
J. Biol. Chem.
272:24617-24623 |
| 125. | King, A. J., and P. C. van der Vliet. 1994. A precursor terminal protein-trinucleotide intermediate during initiation of adenovirus DNA replication: regeneration of molecular ends in vitro by a jumping back mechanism. EMBO J. 13:5786-5792[Medline]. |
| 126. | Kornberg, A., and T. A. Baker. 1992. DNA replication. W. H. Freeman & Co., New York, N.Y. |
| 127. |
Krawiec, S.,
F. Jiménez,
J. A. García,
N. Villanueva,
J. M. Sogo, and M. Salas.
1981.
The orderly, in vitro emergence of DNA from bacteriophage 29 particles.
Virology
111:440-454[CrossRef].
|
| 128. | Kumar, A., R. A. Malloch, N. Fujita, D. A. Smillie, A. Ishihama, and R. S. Hayward. 1993. The minus 35 recognition region of Escherichia coli sigma 70 is inessential for initiation of transcription at the "extended minus 10" promoters. J. Mol. Biol. 232:406-418[CrossRef][Medline]. |
| 129. |
Lemon, K. P., and A. D. Grossman.
1998.
Localization of bacterial DNA polymerase: evidence for a factory model of replication.
Science
282:1516-1519 |
| 130. | Liebowitz, P. J., and M. Schaechter. 1975. The attachment of the bacterial chromosome to the membrane. Int. Rev. Cytol. 41:1-28[Medline]. |
| 131. | Maniloff, J., H.-W. Ackermann, and A. Jarvis. 1999. Phage taxonomy and classification, p. 1221-1228. In A. Granoff, and R. G. Webster (ed.), Encyclopaedia of virology, 2nd ed. Academic Press, Ltd., London, United Kingdom. |
| 132. | Martín, A. C., L. Blanco, P. García, M. Salas, and J. Méndez. 1996. In vitro initiation of pneumococcal phage Cp-1 DNA replication occurs at the third 3' nucleotide of the linear template: a stepwise sliding-back mechanism. J. Mol. Biol. 260:369-377[CrossRef][Medline]. |
| 133. |
Martín, G.,
J. M. Lázaro,
E. Méndez, and M. Salas.
1989.
Characterization of the phage 29 protein p5 as a single-stranded DNA binding protein. Function in 29 DNA-protein p3 replication.
Nucleic Acids Res.
17:3663-3672 |
| 134. |
Meijer, W. J. J.,
P. J. Lewis,
J. Errington, and M. Salas.
2000.
Dynamic relocalization of phage 29 DNA during replication and the role of the viral protein p16.7.
EMBO J.
19:4182-4190[CrossRef][Medline].
|
| 135. |
Meijer, W. J. J.,
A. Serna-Rico, and M. Salas.
2001.
Characterization of the bacteriophage 29-encoded protein p16.7: a membrane protein involved in phage DNA replication.
Mol. Microbiol.
39:731-746[CrossRef][Medline].
|
| 136. |
Mellado, R. P.,
I. Barthelemy, and M. Salas.
1986a.
In vitro transcription of bacteriophage 29 DNA. Correlation between in vitro and in vivo promoters.
Nucleic Acids Res.
14:4731-4741 |
| 137. |
Mellado, R. P.,
I. Barthelemy, and M. Salas.
1986b.
In vivo transcription of bacteriophage 29 DNA early and late promoter sequences.
J. Mol. Biol.
191:191-197[CrossRef][Medline].
|
| 138. |
Mellado, R. P.,
F. Moreno,
E. Viñuela,
M. Salas,
B. E. Reilly, and D. L. Anderson.
1976.
Genetic analysis of bacteriophage 29 of Bacillus subtilis: integration and mapping of reference mutants of two collections.
J. Virol.
19:495-500 |
| 139. |
Mellado, R. P.,
M. A. Peñalva,
M. R. Inciarte, and M. Salas.
1980.
The protein covalently linked to the 5' termini of the DNA of Bacillus subtilis phage 29 is involved in the initiation of DNA replication.
Virology
104:84-96[CrossRef][Medline].
|
| 140. |
Mencía, M.,
M. Monsalve,
F. Rojo, and M. Salas.
1996.
Transcription activation by phage 29 protein p4 is mediated by interaction with the subunit of Bacillus subtilis RNA polymerase.
Proc. Natl. Acad. Sci. USA
93:6616-6620 |
| 141. |
Mencía, M.,
M. Monsalve,
F. Rojo, and M. Salas.
1998.
Substitution of the C-terminal domain of the Escherichia coli RNA polymerase subunit by that from Bacillus subtilis makes the enzyme responsive to a Bacillus subtilis transcriptional activator.
J. Mol. Biol.
275:177-185[CrossRef][Medline].
|
| 142. |
Mencía, M.,
M. Monsalve,
M. Salas, and F. Rojo.
1996.
Transcriptional activator of phage 29 late promoter: mapping of residues involved in interaction with RNA polymerase and in DNA bending.
Mol. Microbiol.
20:273-282[CrossRef][Medline].
|
| 143. |
Mencía, M.,
M. Salas, and F. Rojo.
1993.
Residues of the Bacillus subtilis phage 29 transcriptional activator required both to interact with RNA polymerase and to activate transcription.
J. Mol. Biol.
233:695-704[CrossRef][Medline].
|
| 144. |
Méndez, J.,
L. Blanco,
J. A. Esteban,
A. Bernad, and M. Salas.
1992.
Initiation of 29 DNA replication occurs at the second 3' nucleotide of the linear template: a sliding-back mechanism for protein-primed DNA replication.
Proc. Natl. Acad. Sci. USA
89:9579-9583 |
| 145. |
Méndez, J.,
L. Blanco,
J. M. Lázaro, and M. Salas.
1994.
Primer-terminus stabilization at the 29 DNA polymerase active site. Mutational analysis of conserved motif TX2GR.
J. Biol. Chem.
269:30030-30038 |
| 146. | Méndez, J., L. Blanco, and M. Salas. 1997. Protein-primed DNA replication: a transition between two modes of priming by a unique DNA polymerase. EMBO J. 16:2519-2527[CrossRef][Medline]. |
| 147. | Miyagi, T. 1985. Studies on phage structures coded by bacteriophage M2. Ph.D. thesis. Graduate School of Biological Science. Sophia University, Tokyo, Japan. |
| 148. |
Monsalve, M.,
B. Calles,
M. Mencía,
M. Salas, and F. Rojo.
1997.
Transcription activation or repression by phage 29 protein p4 depends on the strength of the RNA polymerase-promoter interactions.
Mol. Cell
1:99-107[CrossRef][Medline].
|
| 149. |
Monsalve, M.,
M. Mencía,
F. Rojo, and M. Salas.
1995.
Transcription regulation in Bacillus subtilis phage 29: expression of the viral promoters throughout the infection cycle.
Virology
207:23-31[CrossRef][Medline].
|
| 150. |
Monsalve, M.,
M. Mencía,
F. Rojo, and M. Salas.
1996.
Activation and repression of transcription at two different phage 29 promoters are mediated by interaction of the same residues of regulatory protein p4 with RNA polymerase.
EMBO J.
15:383-391[Medline].
|
| 151. |
Monsalve, M.,
M. Mencía,
M. Salas, and F. Rojo.
1996.
Protein p4 represses phage 29 A2c promoter by interacting with the subunit of Bacillus subtilis RNA polymerase.
Proc. Natl. Acad. Sci. USA
93:8913-8918 |
| 152. | Moran, C. P., N. Lang, S. F. J. LeGrice, G. Lee, M. Stephans, A. L. Sonenshein, J. Pero, and R. Losick. 1982. Nucleotide sequence that signal the initiation of transcription and translation in Bacillus subtilis. Mol. Gen. Genet. 186:339-346[CrossRef][Medline]. |
| 153. |
Moreno, F.,
A. Camacho,
E. Viñuela, and M. Salas.
1974.
Suppressor-sensitive mutants and genetic map of Bacillus subtilis bacteriophage 29.
Virology
62:1-16[CrossRef][Medline].
|
| 154. |
Müller, D. J.,
A. Engel,
J. L. Carrascosa, and M. Vélez.
1997.
The bacteriophage 29 head-tail connector imaged at high resolution with the atomic force microscope in buffer solution.
EMBO J.
16:2547-2553[CrossRef][Medline].
|
| 155. |
Nelson, R. A.,
B. E. Reilly, and D. L. Anderson.
1976.
Morphogenesis of bacteriophage 29 of Bacillus subtilis: preliminary isolation and characterization of intermediate particles of the assembly pathway.
J. Virol.
19:518-532 |
| 156. | Newport, J., and H. Yan. 1996. Organization of DNA into foci during replication. Curr. Opin. Cell Biol. 8:365-368[CrossRef][Medline]. |
| 157. |
Nuez, B.,
F. Rojo, and M. Salas.
1992.
Phage 29 regulatory protein p4 stabilizes the binding of the RNA polymerase to the late promoter in a process involving direct protein-protein contacts.
Proc. Natl. Acad. Sci. USA
89:11401-11405 |
| 158. |
Nuez, B., and M. Salas.
1993.
Bacteriophage Nf DNA region controlling late transcription: structural and functional homology with bacteriophage 29.
Nucleic Acids Res.
21:2861-2865 |
| 159. |
Ortín, J.,
E. Viñuela,
M. Salas, and C. Vásquez.
1971.
DNA-protein complex in circular DNA from phage 29.
Nature (London) New Biol.
234:275-277[CrossRef].
|
| 160. |
Otero, M. J.,
J. M. Lázaro, and M. Salas.
1990.
Deletions at the N-terminus of bacteriophage 29 protein p6: DNA binding and activity in 29 DNA replication.
Gene
95:25-30[CrossRef][Medline].
|
| 161. |
Paces, V.,
C. Vlcek,
P. Urbanek, and Z. Hostomsky.
1986.
Nucleotide sequence of the right early region of Bacillus subtilis phage PZA completes the 19366-bp sequence of PZA genome. Comparison with the homologous sequence of phage 29.
Gene
44:115-120[CrossRef][Medline].
|
| 162. |
Pastrana, R.,
J. M. Lázaro,
L. Blanco,
J. A. Garcia,
E. Méndez, and M. Salas.
1985.
Overproduction and purification of protein p6 of Bacillus subtilis phage 29: role in the initiation of DNA replication.
Nucleic Acids Res.
13:3083-3100 |
| 163. | Pecenkova, T., V. Benes, J. Paces, C. Vlcek, and V. Paces. 1997. Bacteriophage B103: complete DNA sequence of its genome and relationship to other Bacillus phages. Gene 199:157-163[CrossRef][Medline]. |
| 164. |
Pecenkova, T., and V. Paces.
1999.
Molecular phylogeny of 29-like phages and their evolutionary relatedness to other protein-primed replicating phages and other phages hosted by Gram-positive bacteria.
J. Mol. Evol.
48:197-208[Medline].
|
| 165. |
Ponnambalan, S.,
C. Webster,
A. Bingham, and S. Busby.
1986.
Transcription initiation at the Escherichia coli galactose operon promoters in the absence of the normal 35 region.
J. Biol. Chem.
261:16043-16048 |
| 166. |
Prieto, I.,
E. Méndez, and M. Salas.
1989.
Characterization, overproduction and purification of the product of gene 1 of Bacillus subtilis phage 29.
Gene
77:195-204[CrossRef][Medline].
|
| 167. |
Prieto, I.,
M. Serrano,
J. M. Lázaro,
M. Salas, and J. M. Hermoso.
1988.
Interaction of the bacteriophage 29 protein p6 with double-stranded DNA.
Proc. Natl. Acad. Sci. USA
85:314-318 |
| 168. |
Ramirez, G.,
E. Méndez,
M. Salas, and E. Viñuela.
1972.
Head-neck connecting protein in phage 29.
Virology
48:263-265[CrossRef][Medline].
|
| 169. | Reilly, B. E. 1965. A study of the bacteriophages of Bacillus subtilis and their infectious nucleic acids. Ph.D. thesis. Case Western Reserve University, Detroit, Mich. |
| 170. |
Reilly, B. E.,
R. A. Nelson, and D. L. Anderson.
1977.
Morphogenesis of bacteriophage 29 of Bacillus subtilis: mapping and functional analysis of the head fiber gene.
J. Virol.
24:363-377 |
| 171. |
Rojo, F.,
M. Mencía,
M. Monsalve, and M. Salas.
1998.
Transcription activation and repression by interaction of a regulator with the subunit of RNA polymerase: the model of phage 29 protein p4.
Prog. Nucleic Acid Res. Mol. Biol.
60:29-46[Medline].
|
| 172. |
Rojo, F., and M. Salas.
1991.
A DNA curvature can substitute phage 29 regulatory protein p4 when acting as a transcriptional repressor.
EMBO J.
10:3429-3438[Medline].
|
| 173. |
Rojo, F.,
A. Zaballos, and M. Salas.
1990.
Bend induced by phage 29 transcriptional activator in the viral late promoter is required for activation.
J. Mol. Biol.
211:713-725[CrossRef][Medline].
|
| 174. |
Saedi, M. S.,
K. J. Garvey, and J. Ito.
1987.
Cloning and purification of a unique lysozyme produced by Bacillus phage 29.
Proc. Natl. Acad. Sci. USA
84:955-958 |
| 175. | Saier, M. H. 2000. Families of proteins forming transmembrane channels. J. Membr. Biol. 175:165-180[CrossRef][Medline]. |
| 176. | Salas, M. 1991. Protein-priming of DNA replication. Annu. Rev. Biochem. 60:39-71[CrossRef][Medline]. |
| 177. |
Salas, M.
1999.
Bacillus phage 29, p. 119-130.
In
R. G. Webster, and A. Granoff (ed.), Encyclopaedia of virology, 2nd ed. Academic Press, Ltd., London, United Kingdom.
|
| 178. | Salas, M. 1999. Mechanism of initiation of linear DNA replication in prokaryotes. Genet. Eng. 21:159-171. |
| 179. |
Salas, M.,
R. P. Mellado,
E. Viñuela, and J. M. Sogo.
1978.
Characterization of a protein covalently linked to the 5' termini of the DNA of Bacillus subtilis phage 29.
J. Mol. Biol.
119:269-291[CrossRef][Medline].
|
| 180. |
Salas, M.,
J. Méndez,
J. A. Esteban,
M. Serrano,
C. Gutiérrez,
J. M. Hermoso,
A. Bravo,
M. S. Soengas,
J. M. Lázaro,
M. A. Blasco,
R. Freire,
A. Bernad,
J. M. Sogo, and L. Blanco.
1993.
Terminal protein priming of DNA replication: bacteriophage 29 as a model system, p. 3-19.
In
W. Doerfler, and P. Böhm (ed.), Virus strategies. Molecular biology and pathogenesis. VCH, Weinheim, Germany.
|
| 181. | Salas, M., J. T. Miller, J. Leis, and M. L. DePamphilis. 1996. Mechanisms for priming DNA synthesis, p. 131-176. In M. L. DePamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, New York, N.Y. |
| 182. |
Salas, M., and F. Rojo.
1993.
Replication and transcription of bacteriophage 29, p. 843-858.
In
A. L. Sonenshein, J. A. Hoch, and R. Losick (ed.), Bacillus subtilis and other gram-positive bacteria: biochemistry, physiology, and molecular genetics. American Society for Microbiology, Washington, D.C.
|
| 183. |
Salas, M.,
C. Vásquez,
E. Méndez, and E. Viñuela.
1972.
Head fibers of bacteriophage 29.
Virology
50:180-188[CrossRef][Medline].
|
| 184. |
Saturno, J.,
L. Blanco,
M. Salas, and J. A. Esteban.
1995.
A novel kinetic analysis to calculate nucleotide affinity of proofreading DNA polymerases. Application to 29 DNA polymerase fidelity mutants.
J. Biol. Chem.
270:31235-31243 |
| 185. |
Saturno, J.,
J. M. Lázaro,
L. Blanco, and M. Salas.
1998.
Role of the first aspartate residue of the "YxDTDS" motif of 29 DNA polymerase as a metal ligand during both TP-primed and DNA-primed DNA synthesis.
J. Mol. Biol.
283:633-642[CrossRef][Medline].
|
| 186. |
Serna-Rico, A.,
B. Illana,
M. Salas, and W. J. J. Meijer.
2000.
The putative coiled coil domain of the 29 terminal protein is a major determinant involved in recognition of the origin of replication.
J. Biol. Chem.
275:40529-40538 |
| 187. |
Serrano, M.,
C. Gutiérrez,
R. Freire,
A. Bravo,
M. Salas, and J. M. Hermoso.
1994.
Phage 29 protein p6: a viral histone-like protein.
Biochimie
76:981-991[CrossRef][Medline].
|
| 188. |
Serrano, M.,
C. Gutiérrez,
M. Salas, and J. M. Hermoso.
1993.
Superhelical path of the DNA in the nucleoprotein complex that activates the initiation of phage 29 DNA replication.
J. Mol. Biol.
230:248-259[CrossRef][Medline].
|
| 189. |
Serrano, M.,
J. Gutiérrez,
I. Prieto,
J. M. Hermoso, and M. Salas.
1989.
Signals at the bacteriophage 29 DNA replication origins required for protein p6 binding and activity.
EMBO J.
8:1879-1885[Medline].
|
| 190. |
Serrano, M.,
M. Salas, and J. M. Hermoso.
1990.
A novel nucleoprotein complex at a replication origin.
Science
248:1012-1016 |
| 191. |
Shimizu, N.,
K. Miura, and H. Aoki.
1970.
Characterization of Bacillus subtilis bacteriophage. II. Isolation and morphology of phage Nf and properties of its DNA.
J. Biochem. Tokyo.
68:277-286 |
| 192. | Siegel, P. J., and M. Schaechter. 1973. The role of the host cell membrane in the replication and morphogenesis of bacteriophages. Annu. Rev. Microbiol. 27:261-281[CrossRef][Medline]. |
| 193. |
Simpson, A. A.,
Y. Tao,
P. G. Leiman,
M. O. Badasso,
Y. He,
P. J. Jardine,
N. H. Olson,
M. C. Morais,
S. Grimes,
D. L. Anderson,
T. S. Baker, and M. G. Rossmann.
2000.
Structure of the bacteriophage 29 DNA packaging motor.
Nature
408:745-750[CrossRef][Medline].
|
| 194. |
Soengas, M. S.,
J. A. Esteban,
J. M. Lázaro,
A. Bernad,
M. A. Blasco,
M. Salas, and L. Blanco.
1992.
Site-directed mutagenesis at the Exo III motif of 29 DNA polymerase: overlapping structural domains for the 3'-5' exonuclease and strand-displacement activities.
EMBO J.
11:4227-4237[Medline].
|
| 195. |
Soengas, M. S.,
J. A. Esteban,
M. Salas, and C. Gutiérrez.
1994.
Complex formation between phage 29 single-stranded DNA binding protein and DNA.
J. Mol. Biol.
239:213-226[CrossRef][Medline].
|
| 196. |
Soengas, M. S.,
C. Gutiérrez, and M. Salas.
1995.
Helix-destabilizing activity of 29 single-stranded DNA binding protein: effect on the elongation rate during strand displacement DNA replication.
J. Mol. Biol.
253:517-529[CrossRef][Medline].
|
| 197. |
Sogo, J. M.,
M. R. Inciarte,
J. Corral,
E. Viñuela, and M. Salas.
1979.
RNA polymerase binding sites and transcription map of the DNA of Bacillus subtilis phage 29.
J. Mol. Biol.
127:411-436[CrossRef][Medline].
|
| 198. |
Steiner, M.,
W. Lubitz, and U. Bläsi.
1993.
The missing link in phage lysis of Gram-positive bacteria: gene 14 of Bacillus subtilis phage 29 encodes the functional homolog of lambda S protein.
J. Bacteriol.
175:1038-1042 |
| 199. |
Take-Uchi, A.,
O. Makino, and H. Hirokawa.
1998.
Gene 1, one of the dna genes of bacteriophage 29, represses other dna genes through binding to mRNA.
Biochem. Biophys. Res. Commun.
243:566-571[CrossRef][Medline].
|
| 200. |
Take-Uchi, A.,
O. Makino,
K. Matsumoto, and H. Hirokawa.
1995.
Inhibition of protein synthesis from DNA replication genes by the product of gene 1, a dna gene of Bacillus subtilis phage 29.
J. Gen. Appl. Microbiol.
41:507-516.
|
| 201. | Tao, Y., N. H. Olson, W. Xu, D. L. Anderson, M. G. Rossmann, and T. S. Baker. 1998. Assembly of a tailed bacterial virus and its genome release studied in three dimensions. Cell 95:431-437[CrossRef][Medline]. |
| 202. |
Tedin, K.,
A. Resch,
M. Steiner, and U. Bläsi.
1995.
Dual translational start motif evolutionary conserved in the holin gene of Bacillus subtilis phage 29.
Virology
206:479-484[CrossRef][Medline].
|
| 203. |
Tosi, M. E.,
B. E. Reilly, and D. L. Anderson.
1975.
Morphogenesis of bacteriophage 29 of Bacillus subtilis: cleavage and assembly of the neck appendage protein.
J. Virol.
16:1282-1295 |
| 204. |
Trottier, M.,
Y. Mat-Arip,
C. Zhang,
C. Chen,
S. Sheng,
Z. Shao, and P. Guo.
2000.
Probing the structure of monomers and dimers of the bacterial virus 29 hexamer RNA complex by chemical modification.
RNA
6:1257-1266[Abstract].
|
| 205. |
Trottier, M.,
C. L. Zhang, and P. Guo.
1996.
Complete inhibition of virion assembly in vivo with mutant pRNA essential for phage 29 DNA packaging.
J. Virol.
70:55-61[Abstract].
|
| 206. |
Truniger, V.,
L. Blanco, and M. Salas.
1999.
Role of the "YxGG/A" motif of 29 DNA polymerase in protein-primed replication.
J. Mol. Biol.
286:57-69[CrossRef][Medline].
|
| 207. |
Truniger, V.,
L. Blanco, and M. Salas.
2000.
Analysis of 29 DNA polymerase by partial proteolysis: binding of terminal protein in the double-stranded DNA channel.
J. Mol. Biol.
295:441-453[CrossRef][Medline].
|
| 208. | Truniger, V., J. M. Lázaro, M. Salas, and L. Blanco. 1996. A DNA binding motif coordinating synthesis and degradation in proofreading DNA polymerases. EMBO J. 15:3430-3441[Medline]. |
| 209. |
Truniger, V.,
J. M. Lázaro,
M. Salas, and L. Blanco.
1998.
29 DNA polymerase requires the N-terminal domain to bind terminal protein and DNA primer substrates.
J. Mol. Biol.
278:741-755[CrossRef][Medline].
|
| 210. |
Turnquist, S.,
M. Simon,
E. Egelman, and D. Anderson.
1992.
Supercoiled DNA wraps around the bacteriophage 29 head-tail connector.
Proc. Natl. Acad. Sci. USA
89:10479-10483 |
| 211. |
Valle, M.,
L. Kremer,
C. Martinez-A,
F. Roncal,
J. M. Valpuesta,
J. P. Albar, and J. L. Carrascosa.
1999.
Domain architecture of the bacteriophage 29 connector protein.
J. Mol. Biol.
288:899-909[CrossRef][Medline].
|
| 212. | Valpuesta, J. M., J. M. Carazo, and J. L. Carrascosa. 1999. The three-dimensional structure of a DNA translocating machine at 10 Å resolution. Structure 7:289-296[CrossRef][Medline]. |
| 213. | Valpuesta, J. M., and J. L. Carrascosa. 1994. Structure of viral connectors and their function in bacteriophage assembly and DNA packaging. Q. Rev. Biophys. 27:107-155[Medline]. |
| 214. | Valpuesta, J. M., L. E. Donate, C. Mier, L. Herranz, and J. L. Carrascosa. 1993. RNA-mediated specificity of DNA packaging into hybrid proheads. EMBO J. 12:4453-4459[Medline]. |
| 215. |
Villanueva, N., and M. Salas.
1981.
Adsorption of bacteriophage 29 to Bacillus subtilis through the neck appendages of the viral particle.
J. Virol.
38:15-19 |
| 216. |
Vlcek, C., and V. Paces.
1986.
Nucleotide sequence of the late region of Bacillus phage 29 completes the 19285-bp sequence of 29. Comparison with the homologous sequence of phage PZA.
Gene
46:215-225[CrossRef][Medline].
|
| 217. |
Vosknil, M. I., and G. H. Chambliss.
1998.
The 16 region of Bacillus subtilis and other gram-positive bacterial promoters.
Nucleic Acids Res.
26:3584-3590 |
| 218. | Wang, I. N., D. L. Smith, and R. Young. 2000. HOLINS: the protein clocks of bacteriophage infections. Annu. Rev. Microbiol. 54:799-825[CrossRef][Medline]. |
| 219. |
Whiteley, H. R.,
W. D. Ramey,
G. B. Spiegelman, and R. D. Holder.
1986.
Modulation of in vivo and in vitro transcription of bacteriophage 29 early genes.
Virology
155:392-401[CrossRef][Medline].
|
| 220. | Yoshikawa, H., J. H. Elder, and J. Ito. 1986. Comparative studies on the small Bacillus bacteriophages. J. Gen. Appl. Microbiol. 33:39-49. |
| 221. |
Yoshikawa, H.,
T. Friedmann, and J. Ito.
1981.
Nucleotide sequences at the termini of 29 DNA.
Proc. Natl. Acad. Sci. USA
78:1336-1340 |
| 222. | Yoshikawa, H., K. J. Garvey, and J. Ito. 1985. Nucleotide sequence analysis of DNA replication origins of the small bacteriophages: evolutionary relationships. Gene 37:125-130[CrossRef][Medline]. |
| 223. |
Yoshikawa, H., and J. Ito.
1981.
Terminal proteins and short inverted terminal repeats of the small Bacillus bacteriophage genomes.
Proc. Natl. Acad. Sci. USA
78:2596-2600 |
| 224. |
Yoshikawa, H., and J. Ito.
1982.
Nucleotide sequence of the major early region of bacteriophage 29.
Gene
17:323-335[CrossRef][Medline].
|
| 225. | Young, I., I. Wang, and W. D. Roof. 2000. Phages will out: strategies of host cell lysis. Trends Microbiol. 8:120-128[CrossRef][Medline]. |
| 226. |
Young, R.
1992.
Bacteriophage lysis: mechanism and regulation.
Microbiol. Rev.
56:430-481 |
| 227. | Young, R., and U. Bläsi. 1995. Holins: form and function in bacteriophage lysis. FEMS Microbiol. Rev. 17:191-205[CrossRef][Medline]. |
| 228. |
Zaballos, A., and M. Salas.
1989.
Functional domains in the bacteriophage 29 terminal protein for interaction with the 29 DNA polymerase and with DNA.
Nucleic Acids Res.
17:10353-10366 |
| 229. |
Zhang, F.,
S. Lemieux,
X. Wu,
D. St.-Arnaud,
T. C. McMurray,
F. Major, and D. Anderson.
1998.
Function of hexameric RNA in packaging of bacteriophage 29 DNA in vitro.
Mol. Cell
2:141-147[CrossRef][Medline].
|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»